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ABSTRACT 
A Structural Investigation of the Chemokine Dimer 
Interface. (April 2003) 
Garret Lance Hayes 
Department of Biochemistry 
Texas ARM University 
Fellows Adviser: Dr. Patricia LIWang 
Department of Biochemistry 
Macrophage Inflammatory Protein(MIP)-I P is a dimeric protein of the CC 
chemokine subfamily. Interest in both the structure and function of M IP- I P has 
increased rapidly over the past several years, resulting primarily from the discovery that 
MIP-I P has the ability to block infection of white blood cells by HIV. This discovery 
has instigated further inquiry into exactly how the structure of MIP-I P correlates to its 
function and, likewise, to its anti-HIV capacity. 
Of particular interest to us is the contrast between the structure of MIP- I P and a 
similar dimeric protein from thc CXC chemokine subfamily, Interleukin-8 (IL-8). A 
comparison of thc monomeric forms of IL-8 and MIP-I P shows a striking similarity 
between the two proteins. By examining the monomeric subunits of these two proteins, 
one would expect that simflartty in their quaternary structure would follow suit. 
Howcvcr, it has been shown that dimers of MIP- I P and IL-8 differ greatly, with one 
interacting along the first P-strand and C-terminal helix (IL-8) and the other along the N- 
terminus (MIP-I P). Such contrasting quaternary structures for essentially identical 
monomeric subunits is quite rare. 
In order to learn more about the protein-protein interactions that lead to 
dimerization and to more fully understand the chemokine dimmer interface, we 
attempted to alter the sequence of MIP-I P such that it will dimerize in like fashion to IL- 
8, Previous rational mutations have been successful in producing folded monomers but 
led us to believe that a strategy involving random mutagenesis was required for 
formation of the alternate dimer. Randomization coupled with a phage ) selection 
system v as used to search For MIP-I P variants that dimerizc like IL-8. This process has 
thus far produced several variants currently under investigation by NMR. Preliminary 
data suggests that these proteins may exhibit some type of I'oldcd, alternate snucture. 
This workis dedicated to the teachers of Vidar High School. Thankyott for showing me 
the thrills of learning. 
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CHAPTER I 
INTRODUCTION 
An Historical Pers ective on Protein Structure 
Over the past half century, structure determination has proven to be an incredibly 
powerful tool allowing dccp insight into the biological minutiae of the living world. The 
strides taken in thc capacity for structure elucidation are nothing less than phenomenal 
and highlight the rise of structural biology to thc forefront of modern science (Figure 
1. 1) (Smith, 1999; Wuthrich, 2001). With the increased abihty to determine structure 
quickly and accurately, a massive library of structures is hurriedly accumulating that 
serves as a guide to drug design, mechanism elucidation, and protein function. 
However, the ability of scientists to predict structure is much less tangible and 
underlines thc need for even more inquiries into the fundamental properties that lead to 
protein folding (Heringa, 2000). The search for an all-cncompassing structural 
viewpoint is as fervent as ever. Closely linked to this general investigation of the 
structural paradigm is the study of protein dimerization. While much is known about 
what inivtiences dimer association and dissociation, the process of predicting how 
proteins dimerize is still extremely challenging (Cherfils and Janin, 1993; Janin, 1995; 
Shoichet and Kuntz, 1 996; Sternberg et al. , 1998). 
This thesis follows the style and format of the Journal of Biomoiecidar )VMR. 
Figure 1. 1 The evolution of structure. Shown above is the first X-ray 
crystallography structure determined, myoglobin (Kendrew er nI. , 1958) (a). 
Adjacent (b) is a tnol'e t'ccent high reso)ution structure of myoglobin (Takano, 
1984). Reprint permission of Figure (a) granted by the Nature Publishing 
Group. 
Conveniently then, the study of dimerization is one satisfying method to 
investigate protein folding. By studying the processes and interactions that lead to 
dimerization, a firmer grasp of the generic rubric that governs protein folding can be 
realized; such an investigation is the general intent of this thesis. Further elucidation of 
the general protein-protein interactions that lead to dimcrization was accomplished using 
a class of secreted proteins, the chemokines, as models of study. 
Chemokines 
Chemokincs are small (-8-10kDa), secreted proteins involved in the human 
immune response. Derived from the phrase ehemotactic cytokitcec, "chemokine" aptly 
describes their role in the recruitment of white blood cells to sites of infection via 
chemotaxis. In addition to their part in immune system response, chemokines arc also 
involved in several immunological diseases, mcluding rheumatoid arthritis, 
ateriosclcrosis, and most notably AIDS (Baggiolini et al. , 1997; Burke-C~affney et al. , 
2002; Dragic et al. , 1996; Mellado et al. , 2001; Pate) et al. , 2001; Volin et a/. , 1998). 
The chemokine family consists of over 50 proteins grouped into two broad major 
subfamilies (CC and CXC) and two minor subfamilies (C and CXiC) according to the 
arrangement of conserved cystcine residues near the N-terminus. The CC major 
subfamily contains those chemokines with contiguous cysteinc residues while the CXC 
major subfamily consists of chemokines with an interceding residue behvecn the 
conserved cysteines. As will bc demonstrated, chemokincs within a subfamily sharc 
characteristic structural properties (Clorc and Gronenborn, 1995; Fernandez and Lolis, 
2002; Rollins, 1997). 
Some well known chemokines include RANTES, MIP-1I), and MIP-1st (CC 
subfamily) as well as IL-8 and PF-4 (CXC subfamily). Figure 1. 2 details some of the 
roles and properties of common chemokines, 
Chemaki ne Structure 
Chemokine structure has been well documented over thc past decade, leading to 
a wide breadth of knowledge about the structural characteristics that are conserved 
between various chemokines and those unique properties indicative of one particular 
chemokine or chemokine subfamily. Elucidation of the high resolution structure of over 
20 chcmokines has permitted extensive characterization of the conserved chemokine 
structure (Clore et al. , 1990; Chung et al. , 1995; Crump et al. , 1997; Crump et al. , 1998; 
Handel and Domaille, 1996; Kim et al. , 1994; LiWang et al. , 1999; Lodi et al. , 1994; 
Mayer and Stone, 2000; Meunier et al. , 1997; Mizouc et al. , 1999; Qian et al. , 1999; 
Rajarathnam et al. , 2001; St. Charles et al. , 1989; Sticht et al. , 1999; Young et al. , 
1999). These structures demonstrate that chemokines exhibit a conserved monomeric 
fold consisting of three main portions: 
a. ) a htghly disordcrcd N-terminal region followed by 
b. ) a P-sheet comprised of three anti-parallel I)-strands and 
c. ) a C-terminal ot-helix 
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Figure 1. 2 Descriptions of some well-studied chemokines and their properties (Vaddi 
et al. , 1997). 
An example of this characteristic fold is given m Figure I zk 
The quaternary structure of chemokines is more variable than thc well-conserved 
monomeric fold. Although many chemokincs do exhibit some type of quaternary 
structure (for monomeric exceptions see (Crump et al. , 1997; LiWang e( a/. , 1999; 
Mizoue e( a!. , 1999; Rajarathnam et a/. , 2001; Shao et al. , 199g; Sticht et al. , 1999)), 
dimerization among monomeric subunits is segregated according to subfamily 
membership. Those chemokines belonging to the CC subfamily form dimer contacts 
primarily along thc N-terminus, thus forming interactions between thc amino end and the 
opposite subunit. In contrast, CXC chcmokine dimers are constructed primarily by 
interactions along the first P-strands of each unit and between thc C-terminal helix and 
the flexible loop region between P-strand 1 and 2 (Baggiolini, 1997; Fernandez and 
Lolis, 2002). These two dimer types are illustrated in Figure 1. 4. 
The biological relevance of the chemokine dimer is not clearly known (Laurence 
et al. , 2000; Paavola e( a/. , 1998). The inability to demonstrate receptor cross-binding 
by chemokines of different subfamilies does suggest that dimeric structure may play a 
role in receptor recognition (Baggiolini, 1997; LiWang e( al. , 1999). In addition, the 
importance of the N-terminus in receptor activation seems to imply that the N-terminal 
oricntcd dimers of CC chemokines might have some effect on biological function 
(Baggiolini, 1997; Clark-Lewis et al. , 1995; Crump et al. , 1997; Gong and Clark-Lewis, 
1995; Gong e( a/. , 1996; Pakianathan e( al. , 1997; Proudfoot et al. , 1996; Simmons e( 
a/. , 1997; Steitz et a/. , 199g; Struyf et a/. , 1997; Struyf e( a/. , 1999; Weber e( al. , 1996; 
Zhang e( al. , 1994). 
Figure 1. 3 The structure of the CC chemokine RANTES. This 
view demonstrates the typical "chemokine" fold: a disordered 
N-terminus, three antiparallel P-strands, and a C-terminal ot- 
helix (Skelton er a/, , 1995). 
Figure 1. 4 Viiews of the two most common chemokine dimers. At 
top is the CXC chemokine PF-4 (a). At bottom is the CC 
chemokine RANTES (b). These dimer forms are well conserved 
throughout the chemokine subfamilies (Skelton er tt/. , 1995; St. 
Charles et rt/. , 1989) 
Biological Role of Chemokines 
The chemokines play an active role in thc human immune system, mainly as 
recruiters of white blood cells to sites of infection (Fcrnandez and Lolis, 2002). All 
chemokines bind to seven transmembrane domain G-protein coupled receptors linked to 
the initiation of chemotaxis (Baggiolini et al. , 1994; Murphy, 1994). Generally, these 
receptors are designated depending on the ligand subfamily (e. g. CCR or CXCR). The 
exact nature of chemokine receptor binding is currently unclear. While some evidence 
does point toward a "surface binding" model, the specific mteractions that occur 
between the chemokine and receptor are still unclear (Crump et al. , 1997; Meyer and 
Stone, 2001; Pakianathan ei al. , 1997). Furthermore, thc role that chemokinc quaternary 
structure plays in receptor binding is equally nebulous. Recent studies have shown that 
with some CC chemokines, monomeric variants can bind and activate the CCR receptor 
(Laurence et al. , 2000). 
In addition to the significant role that chemokines play m the immunological 
response, thc binding of chemokines to seven transmembrane domain receptors also has 
a dramatic impact on HIV infectious progression. In order to gain entrance to v:hite 
blood cells and proceed with viral infection, HIV recognizes a set of extracellular 
receptors that often include chemokinc receptors. Therefore, inhibition of HIV binding 
can be accomplished by binding of chemokines to their native rcceptors. For example, 
the chemokine MIP-I P recognizes the CCR5 extracellular receptor. By binding to this 
receptor, MIP-I I) can exclude the viral particle from gaining cellular access (I'igure 1. 5) 
(Baggiolini er al. , 1997). 
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Figure 1. 5 The exclusion of HIV from the CCRS receptor. This figure demonstrates how the CC chemokine MIP- 
I P excludes a viral particle from gaining cellular access. Because the CCR5 receptor is required for HIV entrance 
into the host, binding of MIP-I P to its native receptor obstructs HIV from achieving proper CCR5 access. This 
type of HIV interference occurs in many chemokines. 
Chemokines have also been shown to exhibit binding to glycosaminoglycans 
(GAGs), a process which is intricately linked to the chemotaxis of white blood cells 
(Tanaka et a1. , 1993; Springer, 1994). Thc GAG heparin is uniquely interesting since it 
has been shown that its presence is required for the full anti-HIV capacity of some 
chemokines (Burns er rrl. , 1999; Wagner er al. , 1998). The CrAG-chemokine interaction 
is thought to be mainly a function of electrostatic attraction between the negatively 
charged GAG particle and positively charged residues on the chcmokine surface (Amara 
er al. , 1999; Kuschert et al. , 1999; Koopman and Krangel, 1997; Laurencc er aJ. , 2001; 
Lortat-Jacob er al. , 2002). Recent investigations on MIP-I p have further characterized 
this interaction and produced the first NMR spectra at neutral pH of an anti-H IV CC 
chemokine interacting with GAGs (McCornack crrrl. , 2003). 
Using Chemokinex tn 3'rudy Structure 
In what way do can chemokines be used to study the general problem of structure 
determination and morc precisely, the processes that lead to dimcrization? The 
investigation detailed in this thesis will focus primarily on tv o chemokincs: Macrophage 
Inflammatory Protein-I P (MIP-I P) and Interleukin-g (ILS). These two peptides will bc 
used to investigate the nature of the chemokinc dimer interface and, more broadly, the 
general interactions that gcncrate dimers. As will be described, thc structural 
characteristics of these two proteins provide an interesting means to examine at the 
dimerization paradigm. 
12 
The Structures of MIP- I attd IL8 
A cursory comparison of the individual, monomeric structures of CXC 
chemokine IL-8 and CC chemokine MIP-It) shows a striking similarity between the hvo 
proteins; each contains a disordered N-terminal region follovved by three anti-parallel P- 
strands and a C-terminal tz-helix (Figure 1. 6) (Baldwin et al. , 1991; Clorc er rd. , 1990; 
Lodi er al. , 1994). The sequence identity between MIP-IP and IL-8 in 59 selected 
residues (Figure 1. 7) is 20"/~; the root mean square difference between Cot atoms in these 
regions is only I, 6A (Lodi er al. , 1994). Based on this cursory examination, it is not 
unreasonable to further conclude that similarity in the intermolecular, quaternary 
structure would also be demonstrated. However, the functional dimers of MIP-It) and 
IL-8 differ greatly in structure: one dimerizes along thc first t)-strand (IL-8) while the 
other forms contacts along the N-terminus (MIP-It)) (Figurc 1. 8). The type of 
quaternary structure exhibited is indicative of the parent subfamily of each chemokine: 
IL-8 shows a dimerization typical of the CXC subfamily and MIP-I P association is 
indicative of the CC chemokines. However, such contrasting quaternary structures for 
essentially identical monomeric subunits is quite rare; very few instances exist where 
hvo structures containing greater than 15'to sequence similarity dimerize so differently 
(Lodi et al. , 1994; Royer et al. , 1985; Shaanan, et al. , 1991). 
The contrast between MIP-I t) and IL8 dimers immediately proposes a tempting 
question of'protem engineering: given the very similar monomeric structures of the two 
proteins, can one of the chemokines be altered to form a dimcr resembling the other? 
Figure L6 MIP-1P and IL-8 cotnpared. T1BS ftgnr'e detnonstrates thc rnonomerlc slnnlarlty hetween M1P-II) (a) and 
)L-8 (h), Both demonstrate the standard chemokine fold and when overlayed (c) present a fair amount of structura1 
consistency (Clore er nf. , 1990, Lodi er nl, , 1994). 
IL-8 ~ 
I I /II ~ ~ ~ 
20 
20 
30 
30 
g ~ 
40 
50 
) I 
6 ' I' 
50 
) MIP-1P 
Figure 1. 7 Sequence comparison of MIP-I P and IL-8. The amino acids sequences and secondary 
structure of MIP-I P and IL-8 are compared in this figure. The boxed regions indicate areas where 
sequence identity is 20%; sequence similarity is approximately 35%. Regions not included in the 
boxed areas are the variable ¹ermini, the end of the IL-8 helix, and a portion of the IL-8 flexible 
loop connecting strands P I and P2. These regions are the areas of greatest variation between the two 
molecules (Lodi er al. , 1994). 
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Figure 1. 8 MIP- 1 p and IL-8 dimers. Ilere is shown a comparison between the MIP-1(I (a) and 11. -8 (h) quaternary 
structures. Despite having very similar monomeric forms, these two molecules dimerize very differently. MIP-1(I forms 
dnncr contacts pflnlarlly along thc IAI-t~rnus whllc IL"8 rcllcs on Intel'actions ol thc frrst t)-strands as well as thc hchx- 
IOOP Corltaeta. IBSCt boXCS rnorC CloSCly deselrbe thC PCrtlBCBt rCSldues IB dllBCI for lnatlon (Clore Cr ahf 1990; Lodl er al. i 
1994). 
l6 
Such an endeavor would undoubtedly shed much light on the nature of the chemokine 
dimer interface and provide information on the role that the chemokine dimer plays in 
biological function. In addition, the task of switching the chemokine dimer will help to 
garner general knowledge of what is ncccssary to form an alternate quaternary structure. 
Previous Strate ies 
Attempts have previously been made to alter the M[P-IP dimer from its native 
form to an arrangement that more closely resembles the IL-8 dimer. Rational protein 
design was used to logically manipulate the MIP-I P sequence in order to promote the 
formation of an alternate dimer. Since most CC chcmokines require an intact N- 
terminus to accomplish dimerization, all rational designs lacked the first eight amino 
acids of thc MIP-IP molecule; this ensured that no wild-type dimerization could occur. 
Various other mutations were then attempted to force the assumption of an IL-8 dimer. 
These attempts and their relative successes arc summarized in Figure I ah Particular 
notice should be taken of the variant labeled MIPSTART as it will factor greatly into the 
future investigations of this project. The inability of rational mutation to successfully 
produce a folded alternate dimer led to thc conclusion that a different approach was 
needed to realize formation of the alternate dimer. 
MIP-IP 
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HIP (91 
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SAKE LRCQC IKTVSKP FH PWEECKEQVIESGPHCANTWI IVKI'SDGBBI'LED PKEtggIVQIIfoVaEKFf MZIG 
--------TACCFSYTARKLPRIIFVVDPYETSSL--CSQ5'AgrVVQGKRSKQVCADPSESWVQEYVYDLE'gW 
— — — — — — — — TPCCFSYTARKLPRtjt PIMIA~SSL--CSQPjAVVFfgiKRSKQPVCADPSESWVQEY~ 
— — — — — — — — TACCFSYTARKLPRIIFVVNXRVTSSL — — CSQP'AVVFQTKRSKQVCftDPSEjhJV~VVTD~ 
— — — — — — — — TACCFSYTARKLPRttgVYRPIILYVTSSL — — CSQPAVV@QTKRSKigVCADPSEBWV@YVYD~ 
-------TACQCFSYTARKLPRhIFILVZIKYVTSSGPHCSQPAVVPQTKRSKQIVCA'DPSEgfgVfgEYVYDPLKR~ 
Wild-type 
Wild-type 
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Monomer 
Unfolded 
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Unfolded 
Figure 1. 9 Summary of previous rational mutations. This figure depicts the previous attempts at MIP-I P rational mutation to form an 
alternate IL-8 type dimer. Listed at the top are the wild-type sequences of MIP-I P and IL-g. Thc mutants created and their names are listed 
below the wild type sequences. To the right are listed the dimenzation results of the mutations. All mutants were lacking the first eight 
amino acids of the ¹erminus, This was done to prevent a return to the wild-type MIP-I P dimer. The mutant listed as MIPSTART will be 
the template for future randomization schemes. 
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The S ecific Pu ose of this Stud 
As explained, previous rational mutations of MIP-I P have bccn successful in 
producing a set of folded monomers but have failed to produce a stable, alternate IL-8 
type dimer. Therefore, random mutagenesis was proposed as a method to produce 
variants that can be assessed for IL-8 type dimerization. Such an assessment was 
accomplished by implementing a system that easily selects for dimerization. The 
previously designed variant MIPSTART was chosen as the beginning template for 
randomization. The impetus for selecting this variant as thc randomization template was 
as follov:s: 
a. ) MIPSTART is fully monomeric and lacks the first eight residues of the N- 
terminus. Randomization is unlikely to cause reversion back to a wild-type 
MIP-I P dimer as this would require the addition of N-terminal residues. 
Therefore, any dimers produced by randomization must be either IL-8 in 
fashion or an equally intriguing alternate arrangement. 
b. ) MIPSTART already contains some elements of the! L-8 monomer structure 
that in theory, help promote the formation of the IL-8 type dimer (Figure 
1. 10). 
Using MIPSTART as a template for random mutagcncsis in combination with a 
dimerization selection system permitted insight as to why two proteins with such 
comparable monomeric structure form drastically different dimeric arrangements. 
Nuclear magnetic resonance (NMR) spectroscopy was used to analyze any dimeric 
M I PS'I'ART variants produced by thc randomization/selection process. Accomplishing 
Truncation of first 
Qtght t'esklues to e . , 
cliscoufage MIP-type ~Q 
dtmer assocletlons 
fodi' residuetsr of MIP. 1P 
attd eddtttort of the, 
Inst eight. residues, ;of. 
IL-8 to help pro'ittote: 
formation of the IL-8 
dimes 
Fiigure II. 10 Structure of M1PSTART. Graphical representation of MIPSTART 
Illustrating the salient structural features. Regions altered to encourage 11. -8 type 
dimerization are noted. The two residue changes on P 1 (E30V and V28V) are an 
attempt to produce a more hydrophobic area that might assist subunit interaction. The 
hybrid nature of this molecule was the reason for its selection as the randomization 
template. 
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this goal allowed further understanding into what exactly is required to switch the 
quaternary chemokine arrangement and gave insight into the general properties of the 
chemokine dimer interface. 
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CHAPTER II 
THE PHAGE X SYSTEM AND RANDOMIZATION 
Introduction 
The previous chapter detailed that this project will focus on thc randomization of 
a monomeric MIP- I P variant (MIPSTART) with the intent of forcing an IL-g type 
dimer. The randomization of MIPSTART obviously necessitates the implementation of 
some selection system that can expedite the process of mutant analysis. There is a high 
probability that of the thousands of mutants produced by the randomization process, only 
a few will exhibit dimerization. Since direct structural analysis of thousands of mutants 
by NMR would be nearly impossible, a system that can dependably analyze mutants is 
needed. Ideally, this system would possess three main characteristics: 
a. ) Ability to distinguish between the monomeric and homodimeric forms of a 
MIP-I P variant 
b. ) Employmcnt of a selection process through which quaternary form can be 
easily, quickly, and confidently detected 
c. ) Exhibit high-throughput capability that permits elficient selection of 
thousands of variants within a I'easible time table 
Several dil'ferent systems were analyzed in order to find one best tailored to the project 
scope; a selection system based on thc bacteriophage ) was chosen as the most 
appropriate system for the goal at hand. Thc phage A. selection system, developed by Dr. 
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Jim Hu of Texas A&. M University and Dr. Robert Sauer of the Massachusetts Institute of 
Technology, is of great relevance to this endeavor because of its ability to quickly and 
conftdently detect the presence of homodimers. At the time of thc project inception, the 
X system had been used to study dimerization of defined mutants (Zhang er al. , 1999) 
and to study interactions among genomic proteins (Marino-Ramirez and Hu, 2002), but 
had never been applied to a high-throughput analysis of random mutant libraries. The 
implementation of the X system as well as a solution to thc high-throughput problem will 
now be addressed. 
Life C ele of Pha e)v 
The bacteriophage X is an infectious agent of E. cali that exploits and manipulates 
thc host machinery to promote reproduction and proliferation. The life cycle of phage ) 
is indicative of most viral-type infections: the cycle is a continual repetition of the attack, 
usurp, and reproduce mantra. Upon adherence of the bacteriophage to thc host cell 
exterior, infection is begun by injection of linear phage DNA into the cell lumen. This 
linear DNA circularizcs and commences usurpation of host machinery. In the early 
stages of phage DNA transcription, several kcy decisions are made about life cycle 
progression; thcsc decisions determine the fate of the phage life cycle for the immediate 
future. Essentially, there are two options the phage may pursue aAcr initial infection: a 
lytic pathway and a lysogenic pathway. Should environmental conditions exist that are 
conducive to rapid phage proliferation (e. g. a fresh and plentiful nutrient supply), the 
phage will cxccute the lytic pathway. Such a decision results in immediate production of 
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phage DNA and proteins; new phage particles are then constructed and accumulate until 
lysis of the host occurs. This lysis causes dispersion of particles that continue thc 
infectious scheme. Thus, the immediate result of a lytic pathway is destruction of the 
host cell. In contrast, the lysogenic pathway does not result in immediate phage 
reproduction. Environmental conditions that are not pcrmissiblc to rapid phage 
proliferation will cause the phage system to initiate a series of events that lead to 
incorporation of phage DNA into the host genome. The infectious DNA will remain 
incorporated until environmental conditions are permissive, then dissociate from host 
DNA and commence thc lytic pathway. Therefore, the immediate effect of lysogeny is 
continued host vitality. To summarize, the key aspects of phage reproduction are that 
the lytic phase of the phage life cycle leads to cell death (lysis) while thc lysogcnic phase 
results in cell vitality (Prescott e/ a/. , 1999). This life cycle is illustrated in Figure 2. 1. 
Attention shall now be turned to one of the prominent regulators of thc lytic/lysogcnic 
decision: the X repressor. 
The Structure and Role of X Re ressor 
The i3. repressor protein is a kcy regulator of the lysis/lysogeny decision in the 
phage life cycle. The repressor protein, along with several other early transcription 
products, serves to detcrminc thc fate of thc phage and thus, indirectly, the host cell. 
Specifically, the li, repressor is responsible for promoting the establishment of lysogeny 
and halting lytic progress. By binding to specific sites on newly circularized phage 
DNA, li, repressor halts transcription of genes pertinent to maintaining a lytic pathway 
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Figure 2. 1 The phage l life cycle. Shown here is the process of phage X infection. 
The two pathway, lysis and lysogeny, are noted in the figure. The indicated 
transformation from lysogeny to lysis occurs due to environmental cues. However, 
in an abundance of functional k repressor, the phage is typically unable to escape 
lysogeny and the host cell persists. 
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and allows for promotion of the lysogenic option. Essentially, an abundance of X 
repressor will force the phage to proceed through a lysogenic life cycle. 
The method by which k repressor accomplishes such a task is heavily correlated 
to its structure. The reprcssor is 236 amino acids in length and consists of two domains, 
amino and carboxyl, connected by a flexible linker bridge. Dimerization of thc reprcssor 
occurs via protein-protein contacts in the carboxyl domains; binding of DNA is 
exclusively accomplished through a tandum amino domain arrangement (Figure 2. 2). 
This structure allows for the binding of phage DNA and results in the obstruction of 
RNA polymerase transcription of phage genes vital to a lytic life cycle. Thus, 
2, repressor effectively halts the phage processes that would otherwise lead to host 
destruction. 
In summary, two key points concerning the repressor structure are as follows: 
dimerizatton of the repressor is an absolute requisite for binding of thc associated amino 
domains to the phage DNA and this dimerization is facilitated by contacts through the 
carboxyl domains (Lcwin, 2000; Russell, 1996; Snustad and Simmons, 2000). This 
unique structure-function relationship of thc X rcprcssor and its role in the lysis/lysogeny 
decision immediately suggest a method by which the manipulation of the repressor 
structure can provide an easy means for dimcr selection. 
Figure 2. 2 The ) repressor. a) Diagram showing the general 
structure of X repressor in its dimeric form. b) Structure of dimeric l 
repressor N-terminal domains binding to the phage operator (Beamer 
and Pabo„] 992), 
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The Selection S stem Rationale 
The smrctural characteristics of X rcpressor discussed in the previous section 
suggested to Hu and coworkers an ingenious way by which thc life cycle of phage 7 can 
be exploited to test for dimerization. By replacing the C-terminal domain of X repressor 
with a selected peptide, allowing this fusion repressor to propagate within the host cell, 
and then infecting with phage 7. , a simple life-death assay can be achieved for 
dimerization. Should the new fusion repressor maintain the ability to dimerize, the 
infecting phage will be forced into lysogeny and the host will remain robust. In contrast, 
should the fusion repressor fail to dimerize, infecting phage will be able to enter the lytic 
cycle and thus destroy the host. Therefore, this is a simple life-death selection that easily 
and quickly permits analysis of quaternary structure (Hu e( al. , 1990; Hu er al. , 1993; 
Hu, 1995; Kim and Hu, 1995; Reidhaar-OIson et al. , 1991; Zeng, Zhu er rd. , 1997; Zeng, 
Herndon er al. , 1997). This system is diagrammed in Figurc 2. 3. It must be noted that 
the success of the system is dependent on obtaining a phage stock that is deleted for the 
cl gene, the region of the phage DiqA that codes for native X repressor Such a deletion 
is required because the fusion rcpressor will be inn oduced to the host cell via an 
independent plasmid. Production of native X repressor from a phage stock would 
interfere with the life-death selection process. 
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Figure 2. 3 The phage X selection system. The figure illustrates that phage zi can be used 
to select for dimerization by replacing the C-terminal end of the X repressor with a novel 
partner, The presence or absence of protein dimerization can be determined by a simple 
life-death observation. 
Materials and Methods 
Producrion of' Phage Stocks 
Two 50NI phage stocks werc obtained from the lab of Dr. James Hu: phage ). 
KH54 and phage X h80. Both of these phage stocks are deleted for the cl gene and differ 
only in the recognition of the receptors needed to gain initial access to the host cell. The 
significance of this difference will be noted later (see p. XX of this thesis). These phage 
stocks were used to produce new phage for usc in setting up the selection system. The 
protocol for this phage production was also obtained from the Hu laboratory. Serial 
dilutions of existing phage stock» were made to 10, 10", 10, 10 ', and 10 '. 100Iti of 
the 10, 10, and 10 ' dilutions were preadsorbed to MC1061 E. coli cells from an 
overnight culture for thirty minutes. 3ml of tryptone top agar was added to each 
bacterial-phage mixture and then transferred to freshly poured tryptonc agar plates. 
After solidification of top agar, plates were placed into a 37"C oven overnight. 
Subsequently, a plate with well-defined plaques was selected and a single plaque was 
transferred by Pasteur pipette to I ml of Tris-Magnesium (TM). After vortexing, four 
separate mixtures of 200iti of TM-phage and 50Itl MC1061 cells were prepared. 3ml of 
tryptone top agar was added and then transferred to freshly poured tryptone agar plates. 
Incubation of the four plates was carried out at 37'C overnight. 5ml of TM was then 
added to the surface of each phage plate and then sealed and stored at 4"C for 48 hours. 
After this time, the phage-TM mixture was decanted, placed in a 15ml Falcon tube with 
2-3 drops of choloroform, labeled as "stock" and stored at 4'C. Titring of the phage was 
carried out by creating serial dilutions of stock solutions which were used to infect 
MC1061 cells. Plaques were counted and used to calculated the titre in plaque forming 
units (pfu)/ml. In order to achieve optimal infection rates, all stocks were assured to be 
between 10' and 10' pfu!ml. 
Construction of' MIPSTART and IL8 Fusion Repressors 
The first step in establishment of thc ) system was to ensure that thc life-death 
selection works accurately using known controls. To test this, two fusion repressors 
from MIPSTART and wild-type IL-g were crcatcd. As previously mentioned, the 
MIPSTART protein will be the beginning point for random mutagenesis and is a 
monomer. Wild type IL-II, of course, is a dimer, Dr. Jim Hu kindly provided the JH391 
fusion rcpressor plasmid. This plasmid is diagrammed in Figure 2vk JH391 contains 
the N-terminal domain and flexible linker bridge of the ) repressor followed by a lacZ 
stul'fer region. This construct is under the control of a lac promoter. The lacZ stuffer 
can be removed by digestion of the plasmid with the Sall and BamH I enzymes. 
Subsequently, a gene of interest can be inserted adjacent to the flexible linker bridge 
region. When expressed in E. eoii this results in production of the fusion repressor. 
Oligonucleotide primers were used to amplify the MIPSTART and IL-g genes from 
stock miniprcps; a 3' BamHI site and 5' Sall and Nco I restriction sites (the Nco I site is 
for rapid shuttling of thc insert from the JH391 plasmid to the pET-32a(+) expression 
plasmid) were added. PCR products were purified by gel electrophorcsis followed by 
cleanup with a Qiagen Gel Extraction kit Purified PCR products were then digcstcd in a 
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Figure 2. 4 The JH391 plasmid. The JH391 plasmid shown here is used for constructing 
fusion 2, repressors. The N-terminal domain (amino acids 1-132) is marked on the 
plasmid as cl. Before insertion of genes, the lacZ stuffer region is removed by digestion 
with Sall and BamH1 restriction enzymes. Genes of interest are then cloned into the 
vector between the Sall and BamHI restriction sites. Production of the fusion repressor 
is controlled by a lac promoter (dark arrow at I:00) This figure is courtesy of Dr. Jim Hu 
of Texas A&M University. . 
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20pl mixture containing 141tl purified DNA, 21tI New England Biolabs BamH I Buffer, 
21tl New England Biolabs 10X BSA buffer, I ltl New England Biolabs Sall restriction 
enzyme, and 1ltl New England Biolabs BamHI restriction enzyme for three hours, 
Restriction digestions were purified using the Qiagcn PCR purification kit and eluted in 
40pl ddHiO. Concurrently, the JH391 vector was digested in an analogous manner with 
Sall and BamHI restriction enzymes and then purified using gel electrophoresis 
followed by clean up with the Qiagen Ciel Extraction Kit (elution in 40p. l ddHqO). The 
digested plasmid and inserts were then ligated together in 20p. l mixtures containing I Olti 
insert, 41tI vector, 21tl New England Biolabs T4 DNA Ligase Buffer, 3. 51tI water, and 
0. 51tl New England Biolabs T4 DNA Ligase. Ligation was allowed to procccd for 
twenty four hours at 16'C. SNI of the ligation mixtures were transformed into Stratagcnc 
XL-I Blue CaCI. competent cells by heat shock at 42'C and plated onio LB agar plates 
containing ampicillin. After 24 hours ol' growth, individual colonies were picked, grown 
in culture, and DNA was harvested using the Qiagen MINIPREP Kit. The 
JH391MIPSTART and JH391IL8 constructs werc then stored at -20'C in 401tl of 
ddHzO. 
Anal sis of MIPSTART and IL8 Performance 
The JH391MIPSTART and JH391IIJI constructs werc next tested for 
performance in thc J. selection system. JH391MIPSTART and JH391IL8 v ere 
transformed into the AG1688 E. coli cell line obtamed I'rom Dr. Jim Hu and allowed to 
33 
grow overnight. A "cross-streak" test was then performed to examine the success or 
failure of the selection system in analyzing these two proteins. Phage k KH54 was first 
streaked horizontally across an LB agar plate. Next, streaks of cells containing 
constructs to be tested were drawn vertically across the phage line. The vitality of the 
cells at the interface of the two streaks indicates the presence or absence of a functional 
k repressor. Figure 2. 5 shov s the results of this experiment for MIPSTART and IL-8 
constructs. As can be seen, the two constructs perform as expected: MIPSTART, a 
monomer, shows clear signs of necrosis at the phage-bacteria interface while IL-8, a 
dimer, shows complctc vitality. This experiment verifies that the controls, the "starting" 
and "ending" points of the structural study both perform as expected in vi vo. 
Creation of a Hi h-Throu h ut Method 
The success of MIPSTART and I L-8 to perform as expected in the k system 
demonstrates that the selection system is indeed adequate for the purposes of this 
investigation. However, as previously mentioned and as Figure 2. 5 demonstrates, thc 
cross-streak method of dimerization analysis is not conducive io high-throughput 
analysis. The prospect of streaking thousands, or millions, of colonies is simply not 
feasible. Therefore, an expansion of the system to a level where high-throughput is 
possible was conducted. It secmcd that the most straightforward method of 
accomplishing such an expansion was to simply transform MIPSTART and IL-8 into 
AGI 688 E. coli cells and then plate a limited amount of the transformation mixture onto 
Negative controls 
Wild-type IL-8 
Positive controls 
Negative controls 
MiPSTART 
Positive controls 
I I gare 2. 5 Cross-streak of MIPSTART and 11. -8. 'I'he performance of IL-8 (a) and MIPSTART (b) in thc phage ) 
selection system is shown, Positive controls are JH391 constructs containing the entire wild-type X repressor. 
Negative controls are JH391 constructs containing only the b(-ternunal region of the repressor (lacks a dimerization 
domain). Reststance or' senstttvlty to pltage lysis can be determined by exanunatlon of tIte bacterta"phage tnterface, 
This test demonstrates that both MIPSTAKI' and IL-8 perform as expected: IL-8 survives because of'dimerization 
while MIPSTART, a monomer, does not convey phage immunity. 
plates already replete with a phage solution. To test this, 150Itl of the KH54 phage X 
was plated onto LB agar plates followed by IOOItl of AG16gII heat shock nansformation 
mixtures of MIPSTART, IL-g, and appropriate controls on top of thc phage. Early 
experiments in this manner were somewhat successful but led to the appearance of many 
colonies on plates that should not have exhibited any dimerization. It v, as decided that 
the appearance of these colonies was the result of a rather obvious culprit: natural 
selection. By only using onc type of phage in thc experiments, selection was occurring 
for those cells that might have phage resistance from means other than X repressor. 
Therefore, the conclusion was reached that cells should be exposed to more than one 
type of phage. By doing this, the chances of an abnormally resistant bacterium from 
surfacing are significantly reduced. 
The procedure was modified to account for this by platmg 150ItI of KH54 and 
150Itl of h80 phage l onto a plate before addition of transformed cells. The results of 
these experiments are shown in Figurc 2. 6. As can bc scen from this figurc, thc high- 
throughput method of analysis was achieved, with many thousands of colonies 
effectively screened by the phage system. Some false positive colonies do occur in both 
the negative conh ol and MIPSTART plates in Figure 2. 6, but the number is so low (I 
and 4 colonies, respectively) to be almost inconsequential. It can be imagined that such 
a process could be applied to a randomized pool by transformation of the pool into 
AGI 6gg cells that would then be exposed, as above, to phage. 
However, a significant difference in the application of this system to randomized 
libraries is the need to obtain an accurate count of how many possible colonies v erc 
Figure 2. 6 High-throughput selection of MIPSTART and II. -8. Plates coated with 
phage were exposed to cells transformed with JH391 constructs and observed for 
colony growth. Four separate tests were performed: postttve control (a), negattve 
control (b), IL-8 wi'ld-type dimer (c), and MIPSTART monomer (d). Positive and 
negative controls were the same as those described in Figme 2. 5, Observed cell 
growth in (b) and (d) is marked with a hght circle. Although these collonies do 
indicate false positives, overall the system effectively selects against thousands of 
colonies. Only a small portion persist as false positives. The results shown here 
demonstrate that the high-throughput system does indeed accurately select against 
fusion repressors incapable of dimerization. 
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analyzed by the selection process. This need necessitates a slight modification of thc 
process. The transformation of randomized libraries into AC'rl688 E. colr' cells was 
accomplished by electroporation in order to maximize the amount of mutants that can be 
screened by one selection iteration. After successful elcctroporation of a randomized 
library, a small portion ( I /o) of the transformation mixture is separated and plated on I B 
agar plates that do not contain phage. By counting the number of colonies that appear on 
the non-infected plate, extrapolation of the number of colonies screened on the phage- 
exposed plate is possible. In this manner, the number of different variants from a 
randomized pool that have been screened can be estimated. Refinement of this high- 
throughput system has been achieved and it is possible to scrccn up to 180, 000 random 
variants on onc plate. On average, approximately 50, 000 mutants can bc screened on 
one phage-coated plate. The appearance of I'alse positives does occur at a regular rate, 
but never more than 20 colonies during a single selection. Such a small number is easily 
analyzed further by a low-throughput method such as the cross-streak. 
Randomization 
With the successful set up ol'a phage 7 selection system, Ihe next logical step 
was to develop a process by which MIPSTART could be successfully randomized. 
Several possibilities existed that could potentially serve as a randomization protocol. 
fhe use of a "sloppy" polymerase, such as Taq, v"as considered and even attempted, but 
failed to provide the level of randomization desired. This is not unreasonable 
considering that Taq only introduces approximately one base pair change for every 
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20, 000 base pairs replicated, a rate that is fairly useless when working with proteins 
whose genetic sequences are only 200 base pairs long. Other procedures were only 
cursorily examined as they did not give the type and depth of randomization desired. 
The solution that seemed most appropriate was the use of randomized oligonuclcotide 
primers. 
Randomized oligonucleotide primers were ordered directly from Integrated DNA 
Technologies (IDT). When ordering such primers, bases to be randomized v cre 
designated as "N" in the sequence. The primers produced by IDT contained a mixture of 
adenine, cytosine, thymine, and guanine at locations so designated. IDT indicated that 
there was a slight weighting of bases towards adenine and thymine at these locations, but 
that the primer stock provided did contain cvcry possible combination of base 
arrangements. By performing randomization in this manner, not only was an incredible 
range of mutants obtained, but mutagenesis but mutagenesis was directed to regions 
hypothesized to be important for forming the alternate dimcr. In this manner, the 
versatility of random mutagcncsis was combined with rational design to create a very 
powerful mutagenesis scheme. 
Randomization using these primers was accomplished using polymerase chain 
reactions. For randomization of regions within approximately twenty base pairs of the 
5' or 3' termini, a traditional PCR could be performed to create a library of mutants. For 
randomization of regions distant from the termini, a different approach v"as taken. This 
procedure was developed specifically to facilitate randomization of regions in the bulk 
of the gene. The general scheme of the procedure is outlined in Figure 2. 7. This process 
5'-GCT ACC TGC 
3'-CGA TGG ACG 
GGA CTC TTA-3' 
CCT GAG AAT-5' 
*la 1 
random mutagenesis 
Randomized Region 
unaltered Region 
Gene to be 
randomly mutated 
Two PCR reactions each 
giving a portion of the 
target gene 
Combine PCR products 
Extend and amplify. 
Product: Full-length 
gene with retention of 
random region 
Figure 2. 7 Random PCR mutagenesis. The scheme for randomizing regions of the MIPSTART distant from the 5' 
and 3' termini. Random oligonucleotide primers obtained from Integrated DNA Technologies are used to introduce 
base pair substitutions through a series of polymerase chain reactions, 
40 
uses two separate PCRs to accomplish randomization. Initially, two separate but 
complementary oligonucleotides were created for the region to bc randomized. These 
primers were used with terminal oligonucleotide primers to create "half-gene products" 
that were then combined to create a "full-gene product" randomized only in the desired 
region. This randomized gene library was then be analyzed using the X selection system. 
The S stem in Total 
The two main sections of the process used to search for alternate dimers have 
been outlined: thc X selection system and the randomization process. It is the coupling 
of these two processes that allow for a complete methodology by which to change 
MIPSTART from a monomer to an IL-8 type dimer. Once randomization has been 
completed, the randomized gene product and the JH391 plasmid are subjected to 
restriction digestion by Sall and BamH I restriction enzymes. The randomized inserts 
and JH391 plasmid are then ligated together (thc ligation process used for randomized 
products v ill be dcscribcd in Chapter III) and transformation of the ligated product into 
AG1688 E. coli cells by clcctroporation is performed. As mentioned previously, a small 
portion of the transformation mixture is removed and plated under permissive conditions 
to allow accurate counting of the mutants screened. After the screening is complete, 
colonies that thrive on the phage coated plate are harvcstcd and grov n in culture 
overnight. Subsequently, the mutant DNA is harvested usmg a Qiagen Miniprcp Kit. 
Rctransformation of the DNA (by CaClz heat shock) into AG1688 cells is then 
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performed and a cross streak test executed. This second phage test is to ensure that all 
colonies harvested from the initial high-throughput plate are in fact resistant to phage 
based on the dimcrization of 1 repressor and not on artifacts of natural selection. Mutant 
DNA that continually demonstrates the ability to convey phage resistance is then 
shuttled into an expression vector and produced for examination by NMR. 
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CHAPTER III 
ANALYSIS OF RANDOM VARIANTS 
Introduction 
The establishment of a selection system and refincmcnt of a random mutagenesis 
technique described in the last chapter was the staging ground for a concerted 
mutagenesis of the MIPSTART protein. With the means necessary to randomize 
MIPSTART and select for dimerization in place, thc next step was to actually implement 
the randomization/selection scheme. 
There are three areas of MIPSTART that seem to be promising targets for 
randomization: the first P-strand, the loop region between P-strands 1 and 2, and the C- 
terminal tx-helix. Figurc 3. 1 demonstrates the location of these three regions. A 
comparison with Figure 1. 8 immcdiatcly demonstrates that these regions play pertinent 
roles in formation of the IL-8 quaternary structure. In the IL-8 dimer, interactions 
bctv ccn the first i3-strands of opposite subunits help to stabilize the quaternary structure 
through hydrogen bonding and hydrophobic side chain contacts. Mutation of residues in 
the first P-strand has been shown to decrease the ability of IL-8 to self-associate 
(Lowman ei al. , 1997; Rajarathnam er al. , 1994). 
Also playing a key role in maintenance of the IL-8 dimer structure arc thc 
interactions between the C-terminal ct-helix and the P I-P2 loop region. Hydrogen 
bonding between these regions is thought to contribute significantly to IL-8 
Figure 3, 1 Important MIPSTART regions. Areas of MIPST~T 
cons1dered prtme candidates for fandomlzatton are tndtcated shove. 
Comparison of these regions with Figure I. 8 indicates that all three 
highlighted areas participate in II. -8 dimer formation. It is assumed that 
only PI-P2 loop residues near the P-strands participate in dimer 
formation as these residues are most likely to interact with the C- 
terminal helix. 
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dimerization; removal of the last six residues of thc C-terminal IL-8 helix results m a 
completely monomeric variant (Lowman et al. , 1997; Rajarathnam er al. , 1997). 
Thcrc are three areas, therefore, that seem promising avenues for random 
mutagenesis: the first P-strand, the loop region behvccn P I and P2, and the C-terminal 
v;helix. Randomization of these three areas followed by selection with the phage A, 
system was carried out in an attempt to locate possible variants that demonstrate 
formation of the alternate dimcr. 
Materials and Methods 
Randomization of MIPSTzt RT Template 
The JH391MIPSTART template constructed in Chapter II 
texas 
used as a 
randomization template. Complementary ohgonucleotide primers werc used to effect 
randomization in the first t3-strand as described in Chapter II. Randomization of the t31- 
t32 loop region was also carried out using the procedure outlined in Chapter II. Terminal 
oligonuclcotide primers used were complementary to the MIPSTART 5' and 3' ends. 
The terminal 5' oligonuclcotidc primer incorporated Sall and Ncol restriction sites 
before the 5' end of the MIPSTART gene. The terminal 3' primer added a BamHI 
restriction site. Helix randomization was accomplished by traditional PCR using a 
terminal 3' oligonucleotide primer with randomized positions. 
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Rational Mutation of tvt/PSTART 
The rational mutation of MIPSTART loop regions was achieved by 
oligonucleotide primers ordered from Integrated DNA Technologies. Because the 
rational mutations attempted in Chapter 111 occur in internal regions of the M IPSTART 
gene, thc PCR protocol from Chapter I I was adapted as a means to mcorporate these 
rational mutations into the M IPSTART gene. Complementary oligonucleotides 
containing the desired mutations were ordered and used to carry out a PCR procedure as 
described in Chapter II. 
Ligation ofRandomized Variants into JH39/ Plaxmid 
After purification of the randomized DNA library, both the JH391 plasmid and 
the randomized DNA library were subjected to restriction digestion as follows: 14ltl of 
plasmid/library DNA, 2)tl New England BioLabs 10X BSA, 2pl Nev England BioLabs 
BamH I buffer, I ltl Nev; England BioLabs Sall Restriction Enzyme, and litt New 
England BioLabs BamHI restriction enzyme were combined in a 1. 5ml microcentrifugc 
tube and allowed to incubate overnight at 37'C. Both insert and plasmid DNA were run 
on a low melt agarose (1. 7'/0 and 1. 0"/0, respectively) gel containing EtBr for 
purification. Appropriate bands were excised, purified using the Qiagen Gel Extraction 
Kit, and eluted in 40ltl ddHiO, Quantification of DNA was then performed using a 
Beckman DU640 Spectrophotometer. Concentration of DNA was determined using the 
equation (Sambrook et al. , 1989): 
Concentration (ng/Itl) = ODz&ti(Dilution)(50ng/Itl/ODzss) 
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After shaking, 1 pl of cells were plated onto an LB-Kan/Amp 
agar plate for 
determination of colony count and 9001tl of cells were plated 
onto an LB-Kan/Amp agar 
plate pre-treated v'ith 1501tl of phage 7. KH54 and 1501tl 
phage 7. h80, Plates were 
allowed to incubate overnight at 37'C. Subsequently, the 
plates were removed and the 
11tl non-phage plate used to determine colony 
count. Any surviving colonies on the 
phage-treated plate were nansferrcd to 2XYT broth and 
cultured overnight at 37"C. The 
plasmid DNA was then harvested using a Qiagen Miniprep 
Kit. 
Retrandformatitin and Low-Throughput Phage Screen/ng of 
Randomized Variants 
After miniprepping of high-throughput survivors, 
retransformation of harvested 
DNA into AC11688 cells was accomplished using a 
standard CaClt transformation 
procedure. 1 pl of DNA was added to 1001tl of CaClt AG1688 
cells and allowed to 
incubate on ice for 1 hour. Cells were then transferred 
to a 42"C hot v, ster bath and 
incubated for 45s. This was followed by incubation on ice 
for another 2 minutes. 4001tl 
LB v:as added and cells v;erc placed in a shaker 
at 200rpm and 37' for 45 minutes. Cells 
werc then spun at 3000rpm for five minutes in a 
microcentrifuge, the supernatant 
discarded, and resuspension in 1001tl LB achieved. 
This entire 1001tl solution was then 
plated onto an LB-Kan/Amp plate and allowed 
to incubate overnight at 37"C. A colony 
was picked and used in a cross-streak test to 
verify resistance to phage lysis. Those 
variants that showed phage sensitivity after 
retransformation v, cre discarded. 
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Phage System Ejftciencv 
The procedure for phage selection just outlined has been 
characterized to a great 
extent throughout the course of this work. Several key 
factors should be noted when 
working with this system. As detailed in Chapter 
II, a maximum of 180, 000 colonies 
have been successfully screened in one selection 
iteration. However, the average 
number of colonies that can be successfully screened in 
one iteration is approximately 
50, 000. Typically, 2-25 colonies demonstrate phage 
immunity after a selection. Out of 
the colonies that survive the selection process, 
most (-95'/~) were false positives 
detected upon retransformation and cross-streaking. 
The remaining 10'/~ were true 
positivcs that will bc discussed in the next section. 
This efficiency is well within an 
acceptable range. Because of the appearance of false 
positives and the statistical nature 
of phage selection, it is assumed that one must 
screen a number of colonies that is at 
least two times the number of possible mutants 
to claim complete analysis of thc random 
library. For example, if one is working with a pool 
of 2, 000 mutants, selection on at 
least 4, 000 colonies must be performed. 
Sequencing of Surviving Variantx 
Those variants that demonstrated phage resistance 
after restransformation were 
sequenced using the Texas AgtM University 
Gene Technologies Laboratory protocol. 
10pl of miniprep DNA was dried down in a 0. 2ml 
PCR tube using a Savant Speed Vac 
Concentrator and resuspended in 3ltl ddHzO. To this 
were added 2ltl of 5ltM T7 
terminator oligonucleotide primer and 2ltl of BlGDYE 
(obtained from the Gene Tech 
Lab). A sequencing program was then 
executed on an MJ Research 
thermocycler that 
allowed for DNA sequencing. 
The amplified DNA was purified 
from free nucleotides 
by passage over a column 
containing Scphadex G50 resin (for 
removal of free 
nucleotides). This solution was then dried 
using a Savant SpeedVac 
Concentrator and 
shipped to Gene Technologies 
for separation and analysis. 
Shuttling of Surviving Variants to 
pET-32a(+) Expression Vector 
In order to express interesting 
variants, transfer of DNA betv cen 
the Jl-1391 
selection vector to the T7-containing 
pET-32a(+) expression vector was necessary 
(Figurc 3. 2). Amplification of thc variant 
from the J11391 plasmid was 
accomplished 
using PCR with a 5' MIPSTART 
complementary oligonucleotide primer 
and a 3' T7 
terminator oligonucleotide primer. 
This PCR product was purified using 
gel 
elcctrophoresis and a Qiagen Gcl Extraction 
kit. Digestion of the product was 
achieved 
using the Ncol and BamHI 
restriction enzymes in a fashion 
identical to that already 
described. Ligation into a digested 
and purified pET32a( v) plasmid was 
performed as 
follows: I OItl insert, 4Itl plasmid, 
2(tl T4 DNA Ligase Buffer, 3. 5 Itl 
ddHiO, and 0. 5ItI 
T4 DNA ligasc v'erc combined 
and incubated overnight at 
16'C. 5p. l of the raw ligation 
mixture was then added to 1001tl 
of Stratagenc's XL-I Blue CaCI. 
competent cells and 
allowed to incubate on ice for I 
hour. The mixture was then 
transferred to a 42'C hot 
water bath and incubated for 
45s. This was followed by an 
immediate 2 minute 
incubation on ice after which 400Itl 
of LB was added and thc cells were 
placed in a 
shaker at 200rpm and 37"C for 45 
minutes. The cells were then spun 
at 3000rpm for live 
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Figure 3. 2 The pET-32a(+) plasmid. Shown above is the vector map 
for the pET-32a(+) 
expression plasmid . Genes were cloned into the pET 
vector either between Nco1 and 
BamH1 (for protein production with fusion tags) or between Ndel 
and BamH1 (for protein 
production without fusion tags). Cleavage of fusion tags was 
accomplished by 
enterokinase digestion at the site indicated on the map. 
Protelolytic digestion leaves two 
residues, alanine and methionine, as artifacts of the cleavage 
process. This can be avoided 
by producing protein without fusion tags 
(reprint permission granted by EMD Biosciences, 
Inc. , Novagen). 
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minutes, the supernatant decanted, and the 
pellet resuspended in 100(tl LB. The entire 
mixture was plated onto LB-Amp plates 
and allowed to incubate overnight at 
37'C. 
Colonies were selected and placed in LB broth 
overnight and plasmid DNA was 
harvested using the Qiagen Miniprep Kit 
Expression of Variants 
Expression of variants was accomplished using the 
Novagen BL21(DE3) E. coii 
strain. Transformation of variant DNA in the 
pET-32a(+) plasmid into CaClq competent 
BL21 cells was accomplished by heat shock 
transformation as already described. A 
colony was then picked and grown in 
2ml 1. B culture at 37"C to an ODss&& of 0. 7-0. 9, 
an 
g001tl sample removed for glycerol 
preparation (15'1» glycerol, g5 "/» cell culture), and 
then induced by addition of 1mM (PTG. Growth 
was contmued for another 2 hours and 
then a 200pl sample was removed and prepared 
for analysis by SDS-PAGE. Large scale 
production and isotopic labeling of protem was 
achieved by addition of 200pl of the 
previously prepared glycerol freeze to a 
100ml minimal media solution containing 
N is 
ammonium chloride as the exclusive source 
of nitrogen. This culture was allowed to 
shake overnight at 37'C and 200rpm. 35ml of the 
100ml culture v, as then added to a 1L 
minimal media preparation containing N 
ammonium chloride as the nitrogen source ls 
and allowed to grow to an OD»so of 0. 8. Samples 
were taken for SDS-PAGE analysis 
and glycerol stock preparation and then 
1 mM 1PTG added. Grov'th was allowed 
to 
continue for another 4 hours and then 
another sample for SDS-PACiE analysis 
was 
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removed. Cells were then spun down in 
a Sorvall RC-5B centrifuge using a GS3 
rotor at 
6000rpm for thirty minutes and then placed 
in a -20' freezer for storage. 
SDS-PAGE Analysis 
SDS-PAGE was used to ensure proper protein 
expression. SDS-PAGE samples 
were prepared by addition of 2X loading 
buffer to samples followed by boiling 
for five 
minutes. 101tl of each sample was loaded into 
a 17"to polyacrylamidc tricine gcl 
with a 
4"/0 stacking layer. Electrophoresis was 
carried out at 60V for 20 minutes followed by 
a 
120V segment for 1 hour. Gels were 
stained in 50'/o methanol, 10'yo acetic acid, 
and 
40'l~ Coomasie Blue Stock, Removal of excess dye 
was achieved by rinsing v:ith this 
same solution lacking the Coomasie 
Blue stain. 
Isolation of Prt&rein 
Cells stored at -20' were rcsuspended in 20 
ml of a high salt cracking buffer 
containing 500mM NaCl, 20mM Tris (pH 8), 1 mM 
EDTA, 5mlvl P-mercaptoethanol, 
and 5mM benzamidine. Cells v, ere 
then lysed by French pressing at 16000psi 
tv o times 
followed by centrifugation at 19, 000g for 1 
hour. Supernatants were decanted and 
the 
pellet resuspended in 10ml of denaturing 
buffer containing 5M guanidinium-HCl, 
50mM 
NaCl, 20mL Tris(pH 8), lmlvl ED1 A, and 5mM 
P-mercaptocthanol and allowed to sit at 
room temperature for 2 hours. The 
solution v:as centrifuged at 15, 000g for 30 
minutes 
and thc supernatant refolded by 
introduction into a refolding buffer of same 
composition 
minus the denaturing agent. The rcfolding 
was accomplished by drop-v, ise 
addition over 
the course of thirty minutes. The protein was then allowed to 
continue refolding at room 
temperature for another 2 hours. Thc solution was centrifuged 
at 10, 000g for thirty 
minutes and the supernatant dialyzed against a 2L solution 
of 20mM Tris (pH 8) at 4'C. 
Buffer was switched twice at six hour intervals and upon 
completion of dialysis the 
solution was centrifuged at 10, 000g for 20 minutes. The 
supernatant was removed and 
stored at 4'C. For some variants, purification v, as also attempted by 
isolating protein 
from the lysis supernatant after French Pressing. In 
this case, thc supernatant isolated 
after cell lysis by French Pressing was not refolded but 
immcdiatcly purified using a 
Ni" saturated HiTrap chelating column, 
Purifieaiion of Variants 
Proteins inserted into the pET-32a(+) plasmid usmg thc Nco I-BamH I 
cutting 
scheme are expressed with a variety of fusion tags attached to 
the N-terminus (Figurc 
3. 2). These tags serve to assist in the purification process. AAer 
initial purification is 
complete, these tags may be removed by proteolytic cleavage 
using the protease 
enterokinase. Cleavage in this manner adds an additional 
two residues to the end of the 
target protein (alaninc and methionine, in that order). 
Most variants were initially purified by pellet refolding 
and then subjection to 
reverse phase high performance liquid chromatography 
on a Vydac C4 column. 
Refolded pellets after dialysis were adjusted to a pH of 2. 5 using 
trifluoroacctic acid 
(-0. 1% vol/vol TFA) and adjusted to a composition of 10% acctonitrile. The column 
was rinsed at Sml!min with 40ml of 10% acetonitrile, 90% ddHtO, 
both at 0. 1% TFA. 
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Protein was loaded onto the column at a rate 
of 2-4mVmin and then the column was 
rinsed with an additional 20ml of 10'/o acetonitrile, 
90/v ddH 0 (0. 1 /MFA). A gradient 
was applied from 10-100'ro acetonitrilc (0. 1 "/v TFA). Elution 
of protein was monitored 
with absorbance at 280nm. Isolated proteins 
were then collected, lyophilizcd, and stored 
at room temperature in preparation for proteolytic 
cleavage. 
ln some instances, initial purification was 
achieved by nickel affinity 
chromatography using the poly-histidine fusion 
tag. Passage of proteins attached to such 
it 
a tag over a chelating resin containing Ni 
results in separation of the target protein 
from most other cellular components. This type 
of purification scheme is used when 
isolation of protein from the cell lysis supernatant 
(after French Pressing) is desired. 
Cell lysis supernatants v ith added NaCI (200mM) were 
passed over one or more 
Pharmacia Hi-Trap Chelating columns charged 
with NiSOq. An Amersham Pharmacia 
system was used to load supernatants onto 
the charged chelating columns at a rate 
of 
2ml/min (an exception to this is the purification of Loop 
Variant 3-this was run at less 
than Iml/min). Columns were washed with 50mM 
Tris (pH 8), 500mM NaCI, and 5mM 
imidazole, then a 50mM imidazole 
"bump" to remove any indiscriminately bound 
proteins. A gradient from 50-500mM imidazolc 
was then applied to remove any protein 
that was bound in significant proportions to 
the column. Absorbance at 280nm was 
used 
to monitor elution of protein. Fractions containing 
the desired protein were collected 
and dialyzed against 20mM Tris (pH 8) at 4"C in preparation 
for proteolytic cleavage. 
After proteolytic cleavage, thc digested protein 
v'as isolated Irom fusion tags by 
reverse phase high performance liquid 
chromatography on a Vydac C4 column. Cleaved 
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proteins were adjusted to a pH of 2, 5 using trifluoroacetic acid (-0. 1/0 TFA) and 
adjusted to a composition of 10/0 acetonitrtle. The column was rinsed at 5ml/min with 
40ml of 10/0 acetonitrile, 90% ddH.  O, both at 0. 1 "/0 TFA. Protein was loaded onto 
the 
column at a rate of 2-4mVmin and then the column was rinsed with an additional 
20ml 
of 10/o acetonitrile, 90'/v ddH20 (0. 1'/vTFA). A gradient was applied from 10-100"/o 
acetonitrile (0. 1'/0 TFA). Again, elution of proteins was monitored with absorbance at 
280nm. Isolated proteins werc then lyophi1 ized and stored at room temperature. 
Proteolytic Cleavage 
Proteins containing an enterokinasc cut site were digested m cutting 
buffer 
(20mM tris[pH 8], 50mM NaCI, 2mM CaCIt). Protein concentration was kept as high 
as 
possible, with thc cutting solution maintaining an absorbance at 
280nm near 0. I-Ovk 
Approximately 0. 2 units of enterokinase per ml was added to thc cutting solution and 
allowed to digest over several days. Progress of the cleavage was monitored by 
SDS- 
PAGE. 
NMR Speeo oseopv 
All spectra werc recorded at 25'C on a Varian Inova 500 or 600 MHz 
spectrometer, These spcctromcters are equipped with xyz-shielded gradient 
triple 
resonance probes. Sample tubes were obtained from Shigemi, Inc. HSQC spectra were 
acquired with 512* points in the 'H (direct), and 128' points in the nitrogen dimension. 
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Spectral width for H was 
approximately 6000-8000Hz and 
for 'N was 1500-1700Hz. 
Referencing was relative to 
DSS, using the method 
described by Wishart et al. 
Results and Anal sis 
Resuitr of' f3t Randomization 
Randomization of the first P-strand 
was targeted to promote 
interaction between 
subunits in an IL-8 type dimer. 
Because of the apparently 
salient role the first ll-strand 
played in formmg the 
1L-8 type dimer, it was 
assumed this w ould be an 
ideal starting 
point for implementing 
the randomization/selection 
process previously developed. 
As 
this was the first attempt 
at randomization using 
thc specialized PCR scheme, 
it was 
unclear the extent to which 
random bases could bc incorporated 
into the oligonucleotide 
primer before annealing 
became too nonspecific. 
To assess this, oligonucleotidc 
primer 
pairs with increasing 
amounts of randomized bases 
were ordered. Specifically, 
primers 
with 3, 4, 9, and 12 randomized 
positions centered on the 
first tl-strand were 
obtained. 
The ability of the primers to 
successfully produce PCR products 
using the randomization 
scheme v, as then assessed 
All primers successfully 
produced amplified DNA 
when 
subjected to the PCR protocol. The 
conclusion was reached that 
there was no hindrance 
to using primers v ith a 
highly randomized 
content, at least up to 12 
positions. To date, 
the efficiency of primers with 
a randomized base content 
higher than 12 has not been 
tested. Sequence analysis 
of randomized products ligated 
into plasmid DNA verified 
that the desired product had 
been produced and that 
positions expected to 
demonstrate 
randomization did indeed present 
such variation (Figurc 3. 3), 
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Randomized ositions 
~ 
n 
Figure 3. 3 Verification of randomization. 
Sequencing of a random library pool 
demonstrated that regions altered via 
PCR random mutagenesis exhibit low 
sequence cohesion. The highlighted 
area marks positions randomized 
using the 
procedure described in Chapter II. These 
positions are clearly ambiguous and 
show that the PCR procedure works 
as predicted. 
Randomization and selection 
of first P-strand variants 
proceeded as described in 
Materials and Ivlethods. Figure 
3. 4 demonstrates the positioning 
of the randomized 
bases and the number of 
possible variants that could 
be produced from such 
randomization. Based on colony 
counts performed during 
the selection process, an 
estimated 400, 000 colonies 
werc screened. This should 
have been sufficient to 
effectively screen all 185, 220 
possible variants. From 
this selection process, two 
variants demonstrated the 
consistent ability to convey 
resistance to phage X. . After 
sequencing of these variants, 
it was discovered that 
both contain stop codons 
engineered 
in P 1 positions. 
The sequences of these 
variants are indicated in 
Figure 3. 5. The 
presence of stop codons in 
the first I)-strand was perplexing 
since it is not entirely 
clear 
why a short (-20 amino acids) 
polypeptide chain 
consistently allows cell 
vitality when 
exposed to phage. lt is 
possible that the dimerization 
of k repressor is brought 
about by 
simple nonspecific 
association of the peptide. 
Formation of disulfide bridges 
between 
the cysteine residues of each 
peptide could also result 
in non-specific 
dimerization. 
Although the reducing 
environment of E. coli would seem 
to preclude this, it is 
not 
entirely unreasonable as 
previous studies using 
this system demonstrate 
that short 
peptides rich in cysteine 
do in fact cause 
dimerization of the k repressor 
amino domains 
(Zhang er al. , 1999). 
Currently, the exact relevance 
of these peptides is unclear 
and further 
investigations into their ability 
to promote repressor 
dimerization is intended. 
One 
possible avenue of inquiry 
would bc to express and purify 
thc entire repressor 
amino 
domain with thc peptide 
attached and investigate 
the structure with NMR. 
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MIP START 
Arg Asn Phe Val Val Asp 
Ala Tyr Val Thr Ser 
Arg Asn Phe Val Val ? 
? ? ? '? :: Ser 
MIP START randomized 
Figure 3. 4 P 1 randomization of 
MIPSTART. Shown above is the 
randomization of the first I5-strand using 
twelve randomized positions. 
The boxed region is the Ii1 boundary. 
The randomized positions allow 
for a total of 185, 220 different peptide 
combinations (including stop 
codons). 
MIPSTART 
P2 P3 F1 
(X 
TACCFSYTARKLP~~~iSSLCSQ~!. , KRS: ', . ' ' PSE~QEP/YDF, 
Pl Variant 1 
tl1 Variant 2 
TACCF SYTARKLP~AL'g~ 
TACCFSYTARKLPRNFVFVPW 
Figure 3. 5 Results of P 1 randomization of 
MIPSTART. Two variants consistently demonstrated 
phage resistance 
after randomization of the first P-strand. The 
sequences of these two variants are diagrammed 
above. 
Results of'Loop Randomization 
The flexible loop region 
following the first j3-strand and 
preceding j)-strand 2 
also seemed an ideal place 
to target randomization. 
As already discussed, 
interactions 
between the C-terminal 
u-helix and this loop region 
arc absolutely necessary 
for 
maintenance of the 1L-8 dimer. 
Therefore, changes in the loop 
region might promote 
interaction with the helix. The 
randomization procedure v as 
conducted as previously 
described in Materials and 
Methods. The location of randomized 
bases was chosen so 
that residues thought important 
for helix interaction were 
altered while other residues 
which already play a dominant 
role in maintaining monomeric 
structure (such as the 
nearby cysteine) were not changed 
(Figure 3. 6). After randomization and 
selection, 
calculations indicated that a 
total of at least 500, 000 different 
colonies had been 
screened; this was judged to be 
sufficient to cover most of the 194, 
481 possible variants. 
From this selection process, 
three variants showed the 
ability to consistently convey 
resistance to phage. Out of these 
three, two contained randomly 
integrated stop codons. 
The third contained codons 
for amino acids in each 
randomized position. The 
sequences 
of these three variants are shown 
in Figure 3. 7. As with the 
j)-strand, variants containing 
stop codons have not yet 
been further characterized. 
However, Loop Variant 3 (LV3) 
was immediately shuttled 
into thc pET-32a(+) plasmid for 
expression and purification. 
Unfortunately, purification of LV3 
proved to be very cumbersome. 
Several 
attempts werc made to 
successfully purify the protein. 
After shuttling to the 
pET-32a(+) 
expression vector, the variant 
was expressed with the 
thioredoxin, poly-Histidine, 
and S 
tags of the pET-32a(+) vector (Figure 
3. 2). initially, the cell lysis pellet 
from French 
MIPSTART 
Loop Variant 1 
Loop Variant 2 
Loop Variant 3 
P1 P2 P 
TACCFSYTARKLP~~~SSLCSQPAVVFQ@KRS -, 
' PSESNVQEYVYQF~S 
TAC C F S YTARKLPRRPVV'W~t P, :;. '-', " '' ' ';-i'! ll:, : +&~iPj~!'$" 
TACCFSYTARKLPR~~Stp 
TACCF S YTARKLP~AViiVS LC S Q 
~%! KRS " P S E 8@V'Q~FM~8 
Figure 3. 7 Results of Pl-P2 loop randomization 
of MIP START. Three variants consistently 
demonstrated phage 
resistance after randomization of the loop 
region. The sequences of these three 
variants are diagrammed above. 
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pressing was refolded and 
purified over a reverse phase 
C4 column as indicated in 
Materials and Methods. The 
trace produced by the 
Amcrsham Pharmacia system 
is 
shown in Figure 3. g. As can be 
seen, very little if any protein 
was eluted from the 
column. Thc fraction containing 
the desired protein was 
collected, lyophilized, and 
digested with enterokinase 
to remove fusion tags. 
This cleavage reaction v as 
again run 
over a reverse phase C4 column 
to separate the protein 
product from fusion tags. 
As 
Figure 3. 8 shows, the amount 
of protein produced was again 
extremely low and 
extraordinarily suspect. Thi» 
protein was collected, lyophilizcd, 
and stored for later 
NMR study. 
ln an attempt to find an 
alternate route to purification 
of LV3, purification from 
the cell lysis supernatant 
was attempted. A large, 
3L cell growth was used to 
express the 
LV3 protein; the supernatant 
after French Pressing was 
passed over a H iTrap 
chelating 
z I- 
column saturated with Ni 
. 
The UV trace 1'or this 
purification is shown in Figure 
3. 9. 
ln this case, only a single, 
low, broad peak elutcd 
from the column. This peak 
was 
collected, dialyzed, and then 
subjected to proteolytic digestion by 
enterokinase. The 
cleavage reaction was then 
passed over a C4 reverse phase 
column for purification. 
Again, only a small amount 
of protein was obtained, 
This protein was collected, 
lyophilized and stored for later 
NMR study. 
The protein isolated from 
both purification schemes 
was used to obtain NMR 
HSQC spectra. 'These HSQC 
spectra for LV3 are shov, n 
in I'igure 3. 10. The poor 
dispersion of peaks and clustering 
towards the center of thc spectra 
indicates an unfolded 
protein. itis not yet clear why 
the LV3 protein was so 
difficult to purify or 
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a 
Undigested LV3 
(-40% Acetonitrile) 
I 
1 
Digested LV3 
„II. 
Figure 3. 8 LV3 Pellet Purification. 
Shown above are UV traces 
at 280nm 
of the purification of LV3. 
Purification before enterokinase 
digestion (a) 
produced a small peak in the 
region expected for MIP- l I). 
Purification after 
enterokinase digestion (b) produced 
several small peaks near 40% 
These 
peaks were pooled together 
and lyophilized. . 
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Undigested LV3 
I 
I 
! 
Digested LV3 . . 
Figure 3. 9 LV3 Supernatant Purification. 
Shown above are UV traces at 
280nm of the 
purification of LV3 supernatant. Purification 
before enterokinase digestion (a) was 
performed over a HiTrap chelating 
column saturate with Ni" and produced a 
broad, 
low peak that was isolated and 
dialyzed. Purification after 
enterokinase digestion (b) 
was performed on a C4 reverse 
phase column and produced a 
single small peak. This 
peak was isolated and lyophilized 
for NMR analysis. 
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Figure 3. 10 HSQC spectra of Loop Variant 3. HSQC 
spectra of Loop 
Variant 3 are shown above. (a) LV3 purified by pellet refolding 
followed 
by enterokinase digestion and 
purification. (b) LV3 purified from cell lysis 
supernatant by a Nii' column followed by enterokinase 
digestion and 
purification. These spectra contain many peaks 
clustered at the center, thus 
indicating that the protein is unfolded in vitro. 
lt is unclear why this protein 
consistently passes the X selection system. 
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why a protein that produces 
seemingly positive results in 
vivo appears unfolded once 
purified. 
An Attempt at Rational 
Mutation 
Because the loop region seemed 
to be extremely important to 
forming the IL-8 
type dimer, a rational 
approach was attempted at 
this area. Rational Loop 
Variant I 
(RLVI) and Rational Loop Variant 2 
(RLV2) were designed to change 
the IvlIPSTART 
loop region to resemble 
more closely the analogous 
IL-8 area. Figure 3. 11 shows the 
changes made in RLV I and 
RLV2 in order to imitate the I 
L-8 loop. These rational 
mutations werc carried out as 
described in Materials and 
Ivlethods and expressed in the 
pET-32a(+) plasmid. These proteins 
were purified as described in 
Materials and 
Methods by refolding of the cell lysis 
pellet followed by proteolytic 
cleavage. An 
HSQC spectrum of both proteins 
was obtained; these spectra 
are shown in Figure 3. 12. 
The clustering of peaks in the 
center indicates that both 
proteins are unfolded. The 
unsuccessful mutagenesis of the loop 
region by both random and 
rational means seems 
to indicate that alteration 
of this area is highly detrimental 
to structure integrity. A 
cysteinc residue involved in 
disulfide bond formation present 
in this area may make this 
region highly sensitive to 
changes. It is possible that any 
mutation made in thc loop 
region will not be beneticial 
to overall structural 
coherence. 
PiIPSTART 
IL-8 
P1 P2 
P3 rz 
--- — 
-TACCFSYTARKLPR11~i;. 
tarYVPSS-L-CSQP1IVSPPQTKRSPv@VC@3PSE~~. . . 
' LYtrX9+~8 
SAKELRC CIKTVSKPFHP 
:. . "' V--'ESGPHCAN: -'I'KLSDG 
'-: DPKE 
Rational Variant I 
Rational Variant 2 
— — 
— — 
— T AC C F S STAR KL P RSEVVDAYVT 
S S GPHC S Q PAVVF Q I KRS ~Q'AD P S E 8~8'tf 
VYDFX~8' 
r 
o 
- - - 
- - 
TACC FEYTARKLPR11FVVItAYVTSG-P-CSQ'RAVrVFrQTKRSKQVCADPSE 
5%V, . E'YVrYItFL~EBS'. 
Figure 3. 11 Rational loop variants of 
MIPSTART. Two rational loop 
variants were created in a further 
attempt to achieve alternate 
dimerization. The sequences of these two 
variants as compared to MIPSTART 
and IL-S are demonstrated above. 
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Figure 3. 12 HSQC spectra of Rational Loop Variants. HSQC 
of Rational 
Loop Variants 1 (a) and 2 (b) are shown. The large clustering 
of peaks 
towards the center of both spectra indicates both 
proteins are unfolded in 
vitro. 
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Continuation of Loop Randomization 
Although the loop region seems 
less than ideal for mutation, 
it was believed that 
continued random mutagenesis 
might be beneficial. Because 
the continued appearance 
of stop codons in the randomization 
process is not desired, new 
oligonucleotide primers 
for the loop region were 
ordered that would partially 
reduce the possibility of stop codon 
appearance. These primers 
were ordered with the specification 
that at the third position 
of a randomized codon every base 
except adenine could be 
inserted. Because adenine is 
the third base in two out 
ot'the three stop codons, this is 
expected to alleviate most of the 
problem of stop codon appearance. 
However, elimination of adenine 
from the third 
position, while not completely 
eliminating any amino acid from 
incorporation, does 
reduce the Iikeghood of incorporating 
some amino acids. The benefit 
of eliminating stop 
codons from passing the screening 
test was judged to outweigh this 
problem. The 
randomized portion of the loop region 
is outlined in Figure 3. 13. 
Randomization and 
selection using this ncw primer 
system was contmued until 
it was felt that all 194, 481 
possible variants had been 
examined (-480, 000 colonies were screened). 
lslo variants 
that consistently passed the 
selection system were detected. 
This lack of positive 
variants is most likely attributed 
to the elimination of the stop 
codons. 
Results of Helix Randomization 
The C-terminal n-helix was 
the last region where 
randomization was bclicved to 
bc necessary. As shown in 1 
igure 1. 8, interactions between 
the helix and the loop region 
are likely to be necessary for 
IL-8 type dimcr formation. Based 
on an analysis of 
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MIP START 
Val Thr Ser Ser Leu Cys Ser Gln Pro 
Ala Val 
Val 
~8; '-, - ": ' ''', . ' '„":;:- NNB NNB 
? ? Ser Leu Cys Ser Gln ? 
? Val 
MIPSTART randomized 
Figure 3. 13 Pl-I12 loop randomization without 
stop codons. Shown above 
is the randomization of the I11-I12 loop 
region using twelve randomized 
positions. The boxed region is the loop 
region. The letter "B" indicates 
substitution of every nitrogenous base except 
adenine. The randomized 
positions allow for a total of 194, 481 
different peptide combinations 
(including stop codons). 
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the structures of 1L-8 and MIP-lP, 
the entire MIPSTART helix 
was not randomized; 
only residues that could 
form potential interactions 
with the loop region were 
included in 
thc randomization process. 
Figure 3. 14 demonstrates this concept 
and diagrams the 
randomized portion of the helix. 
Selection of the randomized helix 
library was carried 
out as previously described. 
Onc of the key advantages of 
helix randomization was the 
reduced role stop codons played 
in the selection process. 
Because the helix is at the 
C- 
terminal end of the protein, a stop 
codon in this region will still 
allow formation of a 
near-intact protem. Also, since 
deletion of helix residues is increasingly 
detrimental to 
dimer formation, it is unlikely 
that incorporation of stop codons 
will promote 
dimerization. This is in contrast 
to randomization of the loop and 
I31 regions v, here stop 
codons produced a short polypeptide 
that did, in theory, promote 
association by some 
non-specific means. 
The success of the helix 
randomization was astounding 
in comparison to 
previous randomization attempts. 
According to colony counts 
approximately 6000 
colonies have been screened, 
an amount that includes a 
significant portion of the 9, 261 
possible mutants produced by 
randomization. Currently, the 
process of producing helix 
mutants and subjecting them to the 
selection process is still ongoing, 
However, four 
variants that demonstrate phage 
immunity have been obtained. 
The sequences of these 
four variants are outlined in 
Figure 3. 15. Although there does 
not seem to be any 
immediate correlation between 
the ammo acid substitutions 
present in these four 
variants, there does seem to be a 
disproportionate number of positively 
charged residues. 
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M1P START 
Phe Leu Lys Arg Ala G1u 
Asn Ser 
Phe ? Lys Arg '? Glu 
Asn '? 
MIPSTART randomized 
Figure 3. 14 Helix randomization of 
MIPSTART. Shown above is the 
randomization of the helix region using 
nine randomized positions. All 
randomized residues are all on thc 
face of the C-terminal helix that 
interacts 
with the loop region. The 
randomized positions allow for a 
total of 9, 261 
different peptide combinations 
(including stop codons). 
MIPSTART 
P1 
Ct 
TAC C F S Y TARKL P RNPVVDAYVT S S LC S Q PAVVFQTKRS 
KQVQAD P S E SXVQEYVYDFLKRAEN S 
Helix Variant 1 
Helix Variant 2 
Helix Variant 3 
Helix Variant 4 
RKLPRB&'VVDAYVT S 
KLP~$~S 
RKLP~i; A''~S 
RKLP~!gtItYVT S 
RS~V'C&3P 
RSKQ~@3P 
RSVP 
RSK~~P 
S L C S Q pAVtVIrQTK 
SLCSQP@~K 
SLCSQP~K 
SLCSQPAM~K 
TACCFSYTA 
TACCFSYTAR 
TACCFSYTA 
TACCFSYTA 
S E BNV~YVYDF PKREEgg 
S E ~~lq3P'gK~ 
S E ~E~~~ 
s E@~~PRKRsgEHg. 
Figure 3. 15 Results of helix randomization of MIP START. 
Four variants consistently demonstrated phage 
resistance 
after randomization of the helix region. The sequences 
of these four variants are diagrammed above. 
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Helix Vanant I (HV I) was shuttled to the pET-32a(+) plasmid and 
inserted 
between thc Ncol and BamHI restriction sites. HVI 
was then expressed and purified by 
Dr. Erik Meyer of the LiWang laboratory. Because 
HV I was inserted between Ncol 
and BamH I, fusion tags were removed by proteolytic 
cleavage. The purified HV I was 
then analyzed by NMR and an HSQC spectrum obtamed. 
This spectrum is shown in 
Figure 3. 16. 
The HVI HSQC spectrum demonstrates several peculiar 
properties. Initially, it 
was believed that there were too few peaks present 
in the spectrum to account for all 
amino acids of the protein. However, expression of HV I 
was analyzed by SDS-PACiE 
and showed that the expression product migrates 
at the expected molecular v eight. It is 
possible that the protein may be slightly unfolded 
and thus some peaks may be clustered 
near the center, 
Subsequent to HVI expression, production of the HV2 
protein v'as begun. The 
HV2 gene was shuttled from the I H391 plasm id 
to the p ET-32a(+) plasmid as described 
in Materials and Methods. As opposed to 
previous constructions using Nco I and 
BamHI in pET-32a(+), HV2 was inserted between the Ndel and 
BamHI restriction sites 
of the pET-32a(+) vector. By doing this, no fusion tags were 
added and a step was 
removed from the purification process (no proteolytic digestion). 
HV2 was simply 
refolded from a cell lysis pellet and purified using 
a single pass on a reverse phase C4 
column. In addition, production of the HV2 protein v ithout 
fusion tags eliminated the 
N-terminal methionine and alaninc residues left as 
a proteolytic artifact. Recent 
77 
105 
~ ~ 115 
15N 
~ ~ +~ 
4 125 
10 
1H 
Figure 3. 16 HSQC spectrum of HVl. Above is shown the HSQC of Helix 
Variant l. The spectrum appears to be lacking enough peaks to account for 
all residues of the HV 1 protein. However, some unfolding may have 
resulted in clustering of peaks near the spectrum center. 
experiments in thc LiWang laboratory suggested that these residues 
might bc detrimental 
to an analysis of thc HV2 NMR data. After successful purification of thc 
HV2 protein 
product, HV3 was also expressed and puritied (both proteins were expressed 
and 
purified by of Dr. Erik Meyer). An HSQC spectrum of each protein was 
obtained 
(Figure 3. 17). Thc spectra of HV2 and HV3 demonstrate significant peak shifting away 
from the M1PSTART HSQC spectrum. This shifting indicates a definite change in 
protein conformation, and the implications of this will now be discussed. 
Helix Variant Significance 
The helix variants HV2 and HV3 presented are most worthy of note because 
they 
appear to differ signiticantly from the original MIPSTART 
template when analyzed with 
NMR (Figure 3. 16). This difference suggests many possibilities, several of which are 
most intriguing to the work at hand. Shifts in peaks on an HSQC spectrum 
indicate a 
change in local environmental conditions for the N-H pair 
affected. I his change can be 
thc result of a nearby residue substitution that slightly alters the surrounding 
environs, or 
it can result from a much larger difference, such as newly formed 
dimcr contacts. The 
amount of shifting seen in HV2 and HV3 is significant, but it is unclear 
if the change is 
large enough to warrant assumption of large, intermolecular alterations. 
However, it is 
not unreasonable to suggest that the shifting observed is the result 
of some type of weak 
dimeric contact affecting certain residues. (t is equally likely that the 
shifting simply 
results from the alteration of the helix and surrounding local environment 
g0 
Determination of which of these possibilities is more accurate requires further structural 
mvcstigation. As peak assignmcnts for these molecules are not yet available, it is 
impossible to know which residues have shifted and the significance that shiit may have. 
Peak assignment will require more time and effort but will be shortly underway. 
In addition, analytical ulnacentrifugation analysis of these mutants and the 
MIPSTART template will begin shortly. Hopefully, this analysis will indicate quickly if 
there is at least some dimeric tendency in the HV2 and HV3 proteins. Should these 
variants present indications of dimerization, a full structural analysis will begin, 
including determination of a high-resolution structure, 
CHAPTER IV 
SUMMARY AND CONCLUSION 
~Srrmmar 
The past three chapters of this thesis have presented and detailed an approach to 
studying the dimcr interface of chemokincs. Chapter I outlined the fundamental basis of 
thc project, including its rclcvancc to chcmokinc biochemistry and structural biology in 
general. The impetus rests largely on a desire to more fully understand the type of 
protein-protein interactions that lead to chcmokinc dimcrization and, more broadly, 
quaternary structure formation in general. As a means of studying this process, a 
methodology was devised that subjected a monomeric MIP-I jl variant titled MIPSTART 
to random mutagenesis and subsequent selection with a unique phage Ir screening 
system. Chapter II described the steps taken to set up and expand the phage I scrccning 
system so that it would best suit the needs of this project. All relevant controls, 
including MIPSTART and the IL-8 wild-type dimer performed as expected m the 
system. A high-throughput method of screening was also devised and a process for 
M IPSTART randomization created. 
Chapter Ill detailed the progress of this project so far, including the successes 
and failures of the randomization. 'sclcction proccdurc to produce an alternate 
MIPSTART dimer. Randomization of the first jI-strand and loop regions ol'ihe 
MIPSTART protein yielded somewhat disappointing results; four short polypcptidcs and 
one full length but unfolded protein were the result of this portion of the process. This 
region of the protein seems recalcitrant to modification. However, the next area of 
randomization, the C-terminal ct-helix, proved much more fruitful. 
Randomization and selection of the C-terminal helix region of MIPSTART 
provided several promising protein variants that may possibly prove worthwhile. HVZ 
and HV3 have been exprcsscd and purified and show considerable deviation from 
MIPSTART when analyzed using an HSQC NMR experiment. This deviance is 
promising, yet must be approached with some skepticism. As discussed in Chapter II, 
more examination of HVZ and HV3 is about to begm in order to better characterize the 
structural characteristics of each protein. 
In addition, the HVI protein was expressed and purified but gave unusual results 
when analyzed v ith NMR. An apparent lack of N-H peaks on the HSQC spectrum 
suggests that this protein is behaving oddly. Further investigation will be nccded. 
These results are promising and indicate at least a partial success of the project 
goal. A discussion of the implications these experiments follows in thc conclusion 
section. 
Conclusion 
An exploration of the options for studying the chcmokine dimer interface and, as 
a part of that, the universal properties that lead to dimerization in general has only just 
begun. The lack of knowledge concerning chcmokine dimerization presents a wide 
array of experimental possibilities with which to investigate the process of monomer 
association. The research presented herc is a significant first step in understanding more 
about what leads to that dimerization and how to manipulate it, but much work remains 
to bc done. The data gained from this project has already influenced thc future direction 
of this research and what steps should be taken to best achieve the alternate dimer. 
Therefore, a discussion of the important conclusions and ideas to be garnered from the 
information presented follows. This discussion will focus on the significance of 
pertinent results as well as future steps that should be taken. 
P strand and Loop Region Variants 
The random variants produced from randomization of thc first P-strand and loop 
regions of the MIPSTART template were less than successful in forming alternate 
dimers. The persistent appearance of truncated variants produced by incorporation of a 
stop codon suggests that the small polypcptides are capable of promoting repressor 
dimerization. How this can be or what significance it may have for the phage system is 
nebulous at best. Thc possibility of further study of these small peptides by NMR 
analysis has not been ruled ouk 
The failure of the single fall-length loop variant (LV3) to demonstrate stable 
structure in vitro raises interesting questions about the sensibility of mutating near thc P 1 
and loop regions. Because MIPSTART is a small protein with a small hydrophobic 
core, it is possible that modification of residues near the center of the protein may simply 
cause too much structural strain and compromise integrity. Thc prcsencc of a cysteine 
involved in disulfide bridge formation within the loop region may also prcscnt problems. 
Any nearby residue substitutions that aff'ect loop orientation may adversely affect 
disulfide formation. As the two disulfide bridges present m the MIPSTART structure 
are extremely important for snuctural integrity, this conclusion is not entirely 
unreasonable. However, this does not mean randomization of this region should be 
abandoned. Predicting the behavior of the cysteine in every possible circumstance is not 
feasible and thcrc may be conditions such that substitution of nearby residue does not 
impair disulfide formation. Randomization of this area is not futile, but it should be 
approached with appreciation for the unique environmental circumstances. 
Randomization for the Future 
The randomization performed throughout the scope of this project has bccn fairly 
extensive, but further randomization is nccded to fully exhaust the wide array of 
possibilities that might help in fortnation of the alternate dimer. As mentioned in 
('hapter III, randomization of the helix is nearing completion. However, as previously 
described, this current strategy of helix randomization is directed so that only residues 
thought to interact with the loop region are mutated. Thc next logical step in helix 
randomization, and one that will shortly begin, is mutation of the entire helix region 
rather than selected residues. This will provide a more general and broader approach to 
the idea of helix randomization. Furthermore, isolation of randomization to only single 
specific areas may be somewhat provincial in outlook, Randomization ol'muliiple sites 
at once v:ould give an even greater pool of variation from which an alternate dimer 
might anse. For example, randomization of the helix and loop regions simultaneously 
v, ould vastly increase the types and numbers ol'potential interactions that can form. 
Similarly, randomization of the P-strand, loop region, and ot-helix concurrently would 
give a vast array of variants that could form many different intermolecular associations. 
While expansion of the randomization scope might serve to create a variant that no 
longer remotely resembles MIPSTART, thc importance of expanding the randomization 
scope in the near future cannot be overemphasized. 
Vice Versu 
The intense scrutiny conducted in this attempt to force MIPSTART to dimerize 
in like fashion to IL-8 raises the interesting query of whether a similar approach can be 
taken for IL-8. In a reversal of thc v ork herc, can an IL-8 monomer be forced to 
dimerize like MIP-I tI? While the answer to this is unknown, the process to achieve such 
a goal is already underway in the LiWang laboratory. Current investigations that are 
modeled closely off of the work done in this project are designed to cxplorc the 
possibility of forming a MIP-type dimer from IL-8 monomers. Obviously, these projects 
are closely intertwined; this interconnection assists in looking at the projects from 
several viewpoints and hopefully will continue to promote ideas for new avenues of 
attack. It will be fascinating to scc what answers come from both of these projects and 
how closely the alternate dimers of each species resemble the wild-type structure they 
are attempting to mimic. 
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Exploring the Heterodimer 
While the main intent of this project has bccn the formation of a MIPSTART 
homodimer that resembles IL-8, the possibility of investigating hetcrodimer formation 
must not be excluded. Formation of a heterodimcr between MIP-I P and IL-8 would be a 
potential springboard for ideas on how to achieve the goal of an alternate homodimer. In 
addition, the achievement of a MIP-IL8 heterodimcr in and of itself would bc a 
significant success. There are several approaches that could be taken to produce a 
hctcrodimer. In analogy to the process employed here, a yeast 2-hybrid system could be 
used to select for heterodimer formation between MIP-I P and IL-8. Also, use of rational 
design to promote association between the two species would no doubt be fruitful. 
Heterodimers could be sought between wild-type MIP-I P and IL-8, between 
MIPSTART and wild-type IL-8, between a monomeric IL-8 (IL8START) and wild-type 
MIP-I P, or, most challenging, a hctcrodimer between MIPSTART and IL8START. 
Regardless of the approach taken, whether it be rational or random, and whether it 
employs the use of biological screening systems or not, the point remains that the search 
for a hctcrodimer could be just as intriguing and informative as the search currently 
underway in this project. 
Sine Die 
In conclusion, presented here is a biochemical vvork on thc chemokine dimer 
interface. In an attempt to investigate protein-protein interactions that generate the 
characteristic chcmokine dimer, random mutagenesis coupled with a phage X selection 
system was used to alter MIP-IP so that it dimerizes in similar fashion to IL-II. While a 
stable alternate dimer of MIPSTART that resembles I L-g has not yet been discovered, 
there is little doubt that such an achievement is rapidly approachmg. Recently produced 
variants show great promise and will be intensely studied in the near future. An outlme 
of future steps that seem necessary to completely satisfy this study on the chemokine 
dimer interface has also been presented. The work conducted on this project v as most 
graciously funded by the National Science Foundation and Pfizer, Inc. . 
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APPENDIX A 
SELECTED PROTOCOLS 
PCR Protocol for Random Mutagenesis 
(for randomization near the 3' terminus) 
Combine in 0. 2ml PCR tube: 
1 ltl Template DNA 
4pl dNTPs 
5 pl Thermopo 1 Buffer 
3p1 5' Sense Oligo Complementary to Template 
3p. l 3' Antiscnse Oligo with randomized positions 
33gl ddH. O 
1 ltl DeepVent DNA Polymerase 
Use the following thermocycle to amphfy DNA with randomization: 
Step 1: 95 "C 30s 
Step 2: 55'C 
Step 3: 72'C 
Rcpcat 30X 
Amplified DNA is then purified by gel electrophoresis 
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PCR Protocol for Random Mutagenesis 
(internal regions of a gene) 
Prepare two simultaneous PCR mixtures in two different 0. 2ml PCR tubes: 
Reaction ¹1 
1 ttl Tcmplatc DNA 
4(tl dNTPs 
5Nl Thermopol Buffer 
3ltl 5' Sense oligo (O. 1mg/ml) complementary to internal region of gene (with 
randomized bases) 
3(tl 3' Antisense oligo complementary to 3' terminus of gene 
33pl ddHtO 
1 ltl DeepVent DNA Polymerase 
Reaction ¹2 
1 pl Template DNA 
4(tl dNTPs 
5(tl Thermopol Buffer 
3(tl 5' Antisense oligo (O. 1mg/ml) complementary to internal region of gcnc 
(with randomized bases) 
3(tl 3' Sense oligo complementary to 5' terminus of gene 
33ltl ddHiO 
11tl DeepVent DNA Polymerase 
Amplify both reactions with the following thermocycle' 
Step 1: 
Step 2: 
Step 3: 
Repeat 30X 
95'C 
55'C 
72'C 
30s 
30s 
30s 
Both "half'-genes" are purified using gel electrophoresis then thc following PCR mixture 
is prepared in a 0. 2ml PCR tube: 
41tl dNTPs 
51tl Thcrmopol Buffer 
4ltl 5' Purified "half-gene" (Reaction ¹1) 
4ltl 3' Purified "half-gene" (Reaction¹2) 
261tl ddH. O 
1 pl DeepVent DNA Polymerase 
Thc following prcamplification thermocycle is then run: 
Step 1: 
Step 2: 
Step 3: 
Repeat 10X 
95'C 
55"C 
72'C 
30s 
30s 
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After preamplification, the following is added to the VCR mixture: 
3pl 5' Terminal Sense Oligo (O. Img/ml) Complementary to Template 
3)tl 3' Terminal Antisense Oligo (O. lmg/ml) Complementary to Template 
The following thermocycle is then run: 
Step 1: 95'C 30s 
Step 2: 55"C 30s 
Step 3: 72'C 30s 
Repeat 30X 
After amplification, thc randomized gcnc is isolated and purified using gel 
electrophorests. 
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Preparation of CaClz Competent Cells 
1. Start overnight with 2-3ml of LB 
2. Add I-2ml of overnight into 100ml LB 
3. Incubate and shake at 200 rpm 
4. Grow to an ODs. -&i of about I 
5. Aliquot culture into two separate (sterile) 50ml tubes 
6. Let stand on ice for 20 minutes 
7. Make 0. 1 M CaClz and put on ice 
8. Centrifuge in swing bucket at 3500 rpm, 10 min, 4oC 
9. Pour off supernatant 
10. Rcsuspend pellet in 16ml of 0. 1 M CaClz per 50 ml culture 
11. Ice for 30-60 min 
12. Centrifuge at 3500 rpm, 10 min, 4'C 
13. Pour off supernatant 
14. Resuspend pellet in 2-4 ml ice cold CaCli per tube. 
15. Repeat step 12-14 two or three times On the final repeat only add I-2ml of 
CaCI, 
16. (Optionall let age 24hrs 
17. If making glycerol freeze add I ml 80'/0 glycerol for cvcry 4ml CaCli suspended 
cells. Pre-chill tubes, 
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Electrocompetent Cell Preparation 
Autoclave beforehand: 
1. 51 10'/o glycerol (usc dcionizcd water!) 
500ml 2XYT 
Two medium size centrifuge bottles 
Proccdurc: 
1. From a freshly streaked plate of cells, pick colonies and inoculate 3 Falcon tubes 
with 2ml of 2XYT each (total of 6ml) 
2. Shake cells overnight at 37'C, 
3. Inoculate 500ml autoclaved 2XYT with 6ml overnight cultures and shake at 37'C 
4. Grov, ' until A6tiii of. 5-. 7 (if this absorbance is not reached within 2. 5-3 hours, 
then cells v:ill NOT be competent) 
5. Prechill the centrifuge rotor to -2'C. Chill 10'/o glycerol on icc. 
6. Centrifuge cells in medium size centrifuge bottles in a cold rotor at 4000rpm for 
15 minutes 
7. Rcmove as much of thc supernatant as possible. It is better to lose a few cells 
than to leave any supernatant behind. 
8. Gently resuspend the pellets in a total of 500ml ice-cold 10'/v glycerol taking care 
NOT to lyse them. 
9. Centrifuge as in step 6. 
10. Resuspend in 250ml of icc-cold 10'/0 glycerol. Centrifuge as in step 6. 
11. Resuspend in 125ml of ice-cold 10/0 glycerol. Centril'uge as in step 6. 
12. Resuspend in a final volume of — I ml ice-cold 10% glycerol. The cell 
concentration should be between I x10 and 3x10 cells/ml. 
13. Make 200pl aliquots of this suspension in 1. 5ml tubes and store at -80'C. 
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lX "N Minimal Media 
To 900ml autoclaved water add: 
10X 'N Minimal Salts 100ml 
Trace Elcmcnts Solution 5ml 
1M MgCh 6H20 
Thiamine(20mg/ml) 
Ampicillin(100mg/m I) 
20'lo Glucose 
5ml 
2ml 
2ml 
40m 1 
10X "N Minimal Salts 
(g per 100m/ of 10K) 
KH2PO4 
K. HPO4 
Na2HPO4 
K2SO4 
NH Gl 
13. 0g 
10. 0g 
9. 0g 
2. 4g 
l. 1 g 
Adjust the pH of the solution to 7. 20-7. 4 using KOH. Autoclave. 
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Trace Elements Solution 
(g/I 00ml) 
Add each ingredtent and v'ait several minutes before adding thc next ingredient. 
Rule of thumb: wait at least 10 minutes between adding each ingredient. 
CaC12 2H, O 
FeSOa 7H 0 
MnClq'4H. O 
CoC1. 6H20 
ZnSO4 7HaO 
CuC12 2H20 
0. 6g 
0. 6g 
0. 115( 
0. 0gg 
0. 07g 
0. 03g 
H1BO3 
(NH4)6Moq0. 4'4HqO 
EDTA (disodium!) 
0. 002g 
0. 025g 
0. 50g 
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APPENDIX B 
TABLE OF OLIGONUCLEOTIDE PRIMERS 
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1112634 IL8 BamHI Anti GCG CGC GGA 
TCC TTA TGA 
ATT CTC AGC 
CC 
Complementary to 
3' end of IL-8 and 
MIPSTART; adds a 
BamHI site to the 
3' end 
1157806 MIP(9) Sall Ncol S CGC GCG TCG 
ACC ATG GCT 
ACC GCC TGC 
TGC TTT TC 
Complementary to 
5' end of 
MIPSTART; adds a 
Sall and Nco1 site 
to the 5' end 
1371219 MIPAYVAENS A28-Y29 Rdm S CGC AAC TTT 
GTG GTA GAT 
GNN NAT GTG 
ACC AGC AGC 
CTC TGC 
Used in 
combination with 
its antiscnse partner 
to introduce 3 
randomized 
positions mto the 
t31 strand 
1371220 MIPAYVAENS A28-Y29 Rdm A GCA GAG GCT 
GCT GGT CAC 
ATN NNC ATG 
TAC CAC AAA 
GTT GCG 
Used in 
combination with 
its sense partner to 
introduce 3 
randomized 
posttions into the 
P I strand 
1394681 MIPAYV Y29 V30 Rdm S GTG GTA GAT 
GCT TNN NNG 
ACC AGC AGC 
CTC 
Used incombination 
with its antisense 
partner to introduce 
4 randomized 
positions into the 
P I strand 
1394682 MIPAYV Y29 V30 Rdm A GAG GCT GCT Used in 
106 
GGT CNN NNA 
AGC ATC TAC 
CAC 
combination with 
its sense partner to 
introduce 4 
randomized 
positions into the 
I strand 
1421679 MIP9AYV D27-V30 Rdm S CGC AAC TTT 
GTG GTA GAT 
GNN NNN NNN 
NTG ACC AGC 
AGC CTC TGC 
Used in 
combination with 
its antisense partner 
to introduce 9 
randomized 
positions into the 
P I strand 
14216110 MIP9AYV D27-V30 Rdm A GCA GAG GCT 
GCT GGT CAN 
NNN NNN NNC 
ATC TAC CAC 
AAA GTT GCG 
Used in 
combination with 
its scnsc partner to 
introduce 9 
randomized 
positions into the 
PI strand 
1704416 MIPAYV D27-T31 Rdm S CCT CGC AAC 
TTT GTG GTA 
GNN NNN NNN 
NNN NCC AGC 
AGC CTC TGC 
TCC 
Used in 
combination with 
its antisense partner 
to introduce 12 
randomized 
positions into the 
P I strand 
1704417 MIPAYV D27-T31 Rdm A GGA GCA GAG 
GCT GCT GGN 
NNN NNN NNN 
NNC TAC CAC 
AAA GTT GCG 
AGG AAG 
Used in 
combination v ith 
its sense partner to 
introduce 12 
randomized 
positions into the 
I strand 
2752449* MIP Loop Rdm S GTA GAT TAC 
TAT GAG NNN 
NNN AGC CTC 
TGC TCC CAG 
Used in 
combination with 
its antiscnse partner 
to introduce 12 
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NNN NNN GTG 
GTA TTC CAA 
ACC 
randomized 
positions into the 
t)l- 2 loop 
2752480* MIP Loop Rdm A GGT TTG GAA 
TAC CAC NNN 
NNN CTG GGA 
GCA GAG GCT 
NNN NNN CTC 
ATA GTA ATC 
TAC 
Used in 
combination with 
its sense partner to 
introduce 12 
randomized 
positions into thc 
P I-P2 loop 
4032370 MIP9 Loop Rdm NOA S GTA GAT GCT 
AGA GTG NNB 
NNB AGC CTC 
TGC TCC CAG 
NNB NNB GTG 
GTA TTC CAA 
ACC 
Used in 
combination with 
its antisense partner 
to introduce 12 
randomized 
positions mto thc 
PI-t)2 loop; reduces 
stop codon 
a earance 
4232861 MIP9 Loop Rdm NOT A GGT TTG GAA 
TAC CAC VNN 
VNN CTG GGA 
GCA GAG GCT 
VNN VNN CAC 
TCT AGC ATC 
TAC 
Used in 
combination with 
its sense partner to 
introduce 12 
randomized 
positions into the 
P I-P2 loop; reduces 
stop codon 
appearance 
5011087 MIP(9) Sall Ncol Fxt S CGC GCG TCG 
ACC ATG GCT 
ACC GCC TGC 
TGC TTT TCT 
TAC ACC 
Complementary to 
5' end of 
MIPSTART but 
longer than 
MIP(9) Sall Ncol 
S; adds a Sall and 
Nco1 site to the 5' 
end 
5011088 MIPSTART S33Ci L34P P38T S GTG ACC AGC 
GGC CCT TGC 
Used in 
combination with 
108 
TCC CAG ACC 
GCT GTG GT 
its antisense partner 
to introduce 
internal mutations 
to create Rational 
Loo Variant XX 
5011089 MIPSTART S33G L34P P38T A ACC ACA GCG 
GTC TGG GAG 
CAA GGG CCG 
CTG GTC AC 
Used in 
combination with 
its sense partner to 
introduce internal 
mutations to create 
Rational Loop 
Variant XX 
5419027 MIPSTART HelRdm BamHI A GCG CGC GGA 
TCC TTA NNN 
ATT CTC NNN 
CCT CTT NNN 
AAA GTC ATA 
CAC GTA CTC 
CTG GAC 
Complementary to 
the 3' end of 
MIPSTART; 
introduces 
randomizatton into 
selected residues; 
adds a BamH I site 
6540683 MIPSTART HelTerm BamHI A GCG CGC GGA 
TCC TTA TGN 
NNN NNN NNN 
NNT CTT CAA 
AAA GTC ATA 
CAC GTA CTC 
Complementary to 
3' cnd of 
M IPSTART; 
randomizes 
contiguous bases of 
the helix; adds a 
BamHI site to the 
3 end 
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APPENDIX C 
COMPLETE SEQUENCE OF PLASMID JH391 
EcoRI LacUVS Prnmnter 
1 AATTCTCACTC ATTAGGCACCC CAGGCTTTACA CTTTATGCTTC CGGCTCGT 
TTAAGAGTGAG TAATCCGTGGG GTCCGAAATGT GAAATACGAAG GCCGAGCA 
Lair bde Re Jl essoi N tef'nilltal rlnmaiil 
78 AACAATTTCAC ACACGAAACAG CGTATGAGCAC ~GAAAC CATTAACA 
TTGTTAAAGTG TGTCCTTTGTC GCATACTCGTG TTTTTTCTTTG GTAATTGT 
Lambd~ Repressor N-terminal domain 
155 GCCTTAAAGCA ATTTATGAAAA AAAGAAAAATG AACTTGGCTTA TCCCAGGA 
CGGAATTTCGT TAAATACTTTT TTTCTTTTTAC TTGAACCGAAT AGGGTCCT 
I amhds Repressor N lermine' domain 
Nail 
?32 GGGCAGTCAGG CGTTGGTGCTT TATTTAATGGC ATCAATGCATT AAATGCTT 
CCCGTCAGTCC GCAACCACGAA ATAAATTACCG TAGTTACGTAA TTTACGAA 
Lambna Repressor N termrrtat domain 
309 TCTCAAAGTTA GCGTTGAAGAA TTTAGCCCTTC AATCGCCAGAG AAATCTAC 
AGAGTTTCAAT CGCAACTTCTT AAATCGGGAAG TTAGCGGTCTC TTTAGATG 
Lambda Rr nressnr N-termirat lomain 
386 AGCCGTCACTT AGAAGTGAGTA TGAGTACCCTG TTTTTTCTCAT GTTCAGGC 
TCGGCAGTGAA TCTTCACTCAT ACTCATGGGAC ~GAGTA CAAGTCCG 
Lamlde Re i scr N-teiniiinii rsnma n la 4 Stuffe 
Sall 
463 ACCTTTACCAA AGGTGATGCGG AGAGATGGGTG TCGACGGATCG ATCCCGTC 
TGGAAATGGTT TCCACTACGCC TCTCTACCCAC AGCTGCCTACC TAGGGCAG 
la Z Stuffs 
540 ACCCTGGCGTT ACCCAACTTAA TCGCCTTGCAG CACATCCCCCT TTCGCCAG 
TGGGACCGCAA TGGGTTGAATT AGCGGAACGTC GTGTAGGGGGA AAGCGGTC 
lacZ Stufler 
617 ACCGATCGCCC TTCCCAACAGT TGCGCAGCCTG AATGGCGAATG GCGCTTTG 
TGGCTAGCGGG AAGGGTTGTCA ACGCGTCGGAC TTACCGCTTAC CGCGAAAC 
Iri:Z Stutter 
6 9 4 GCCGGAAAGCT GGCTCGAGTGC GA ' CTTCCTGA GG CCGATACTG TCGTCGT C 
CGGCCTT TCGA CCGACCTCACG CTAGAAGCACT CCGGCTATGAC AGCAGCAG 
lacZ Stuifr. r 
7 7 1 ACGATG C G C C C AT C '1'ACAC CAA CG TAACC TAT C C CAT TAC GGT C AAT C C G C C 
TG C TACGC C GG TAGAT GT GGT T GC AT T GGATAG GGTAATG C CAG n'TAGGCGG 
lacZ Stuffei 
848 GGTTGTTACTC GCTCACATTTA ATGTTGATCAA AGt'TGGCTACA GGAAGGCC 
CCAACAATGAG CGAGTGTAAAT TACAACTAC'I'T TCGACCGATGT CCTTCCGG 
lar, Z Stuffer 
925 TAACTCGGCGT TTCATCTGTGG TGCAACGGGCG CTGGGTCGGTT ACGGCCAG 
ATTGAGCCGCA AAGTAGACACC ACGTTGCCCGC GACCCAGCCAA TGCCGGTC 
la Z Stuffer 
1002 ACCTGAGCGCA TTTTTACGCGC CGGAGAAAACC GCCTCGCGGTG ATGGTGCT 
TGGACTCGCGT AAAAATGCGCG GCCTCTTTTGG CGGAGCGCCAC TACCACGA 
lacZ Stu4fer 
10l79 GAAGATCAGGA TATGTGGCGGA TGAGCGGCATT TTCCGTGACGT CTCGTTGC 
CTTCTAGTCCT ATACACCGCCT ACTCGCCGTAA AAGGCACTGCA GAGCAACG 
rac7 Stuffer 
1156 CGAT'1'TCCATG TTGCCACTCGC TTTAATGATGA TTTCAGCCGCG CTGTACTG 
GCTAAAGGTAC AACGGTGAGCG AAATTACTACT AAAGTCGGCGC GACATGAC 
la Z Stuffer 
1233 AGTTGCGTGAC TACCTACGGGT AACAGTTTCTT TATGGCAGGGT GAAACGCA 
TCAACGCACTG ATGGATGCCCA TTGTCAAAGAA ATACCGTCCCA CTTTGCGT 
larZ Stuffer 
1310 GGCGGTGAAAT TATCGATGAGC GTGGTGGTTAT GCCGATCGCGT CACACTAC 
CCGCCACTTTA ATAGCTACTCG CACCACCAATA CGGCTAGCGCA GTGTGATG 
iacZ Stuffer 
1387 GTC. 'GAGCGCCG AAATCCCGAAT CTCTATCGTGC GGTGCTTGAAC TGCACACC 
CACCTCGCGGC TTTAGGGCTTA GAGATAGCACG CCACCAACTTG ACGTGTGG 
lerZ, , trrffer 
1464 AAGCCTGCGAT GTCGGTT1CCG CGAGGTGCGGA TTGAAAATGGT CTGCTGCT 
TTCGGACGCTA CAGCCAAAGGC GCTCCACGCCT AACTTTTACCA GACGACGA 
I. rcZ Slu'far 
1541 CGAGGCGTTAA CCGTCACGAGC ATCATCCTCTG CATGitTCAGGT CATGGATG 
GCTCCGCAATT GGCAGTGCTCG TAGTAGGAGAC GTACCAGTCCA GTACCTAC 
lacZ StuSer 
1618 GCTGATGAAGC AGAACAACTTT AACGCCGTGCG CTGTTCGCATT ATCCGAAC 
CGACTACTTCG TCTTGTTGAAA TTGCGGCACGC GACAAGCGTAA TAGGCTTG 
lacZ Stuffer 
1695 ACCGCTACGGC CTGTATGTGGT GGATGAAGCCA ATATTGAAACC CACGGCAT 
TGGCGATGCCG GACATACACCA CCTACTTCCCT TATAACTTTGG GTGCCGTA 
lacZ Stuffer 
1772 GATCCGCGCTG GCTACCGGCGA TGAGCGAACGC GTAACGCGAAT GGTGCAGC 
CTAGGCGCGAC CGA GGCCGCT ACTCGCTTGCG CATTGCGCTTA CCACGTCG 
t" cZ Stuflrrr 
f649 CATCTGGTCGC TGGGGAATGA7t TCAGGCCACGG CGCTAATCACG ACGCGCTG 
GTAGACCAGCG ACCCCTTACTT AGTCCGGTGCC GCGATTAGTGC TC:CGCGAC 
'acZ Sruffer 
1926 CTTCCCGCCCG GTGCAGTATGA AGGCGGCGGAG CCGACACCACG GCCACCGA 
GAAGGGCGGGC CACGTCATACT TCCCCCGCCTC GGCTGTGGTGC CGGTGGCT 
ldc2 Stuffm 
2003 GTGGATGAAGA CCAGCCCTTCC CGGCTGTGCCG AAATGGTCCAT C~T 
CACCTACTTCT GGTCGGGAAGG GCCGACACGGC TTTACCAGGTA GTTTTTTA 
larZ Stuffer 
2080 CCCGCTGATCC TTTGCGAATAC GCCCACGCGAT GGGTAACAGTC TTGGCGGT 
GGGCGACTAGG AAACGCTTATG CGGGTGCGCTA CCCATTGTCAG AACCGCCA 
lacZ Stuffer 
'157 GTCAGTATCCC CGTTTACAGGG CGGCTTCGTCT GGGACTGGGTG GATCAGTC 
CAGTCATAGGG O'CAAATGTCCC GCCGAAGCAGA CCCTGACCCAC CTAGTCAG 
lacZ Puffer 
2234 AACCCGTGGTC GGCTTACGGCG GTGATTTTGGC GATACGCCGAA CGATCGCC 
TTGGGCACCAG CCGAATGCCGC CACTAAAACCG CTATGCGGCTT GCTAGCGG 
lacZ Stuffer 
2311 TGCCGACCGC:A CGCCGCATCCA GCGCTGACGGA AGCAAAACACC AGCAGCAG 
ACGGCTGGCGT GCGGCGTAGGT CGCGACTGCCT TCGTTTTGTGG TCGTCGTC 
lacZ Stuffer 
Seel 
2388 AAACCATCGAA GTGACCAGCGA ATACCTGTTCC GTCATAGCGAT AACGAGCT 
TTTGGTAGCTT CACTGGTCGCT 'I'ATGGACAAGG CAGTATCGCTA TTGCTCGA 
t ( N4 Ler. turne Zrppe 
S pe I BamHI 
2465 AACGAAGTTGC GCGCCTGAAAA AACTAGTTGGT GAACGTTGAGG ATCCGGCG 
TTGCTTCAACG CGCGGACTTTT TTGATCAACCA CTTGCAACTCC TAGGCCGC 
I? Ierrmrldtor 
2542 TGAGTTGGCTG CTGCCACCGCT GAGCAATAACT AGCATAACCCC TTGGGGCC 
ACTCAACCGAC GACGGTGGCGA CTCGTTATTGA TCGTATTGGGG AACCCCGG 
77 tern'rnalor EcoRV 
2619 TGCTGAAAGGA GGAACTATATG CCCGGATATCG TCCATTCCGAC AGCATCGC 
ACGACTTTCCT CCTTGATATAC GGGCCTATAGC AGGTAAGGCTG TCGTAGCG 
2696 CTATATGCGTT GATGCAATTTC TATGCGCACCC GTTCTCGGAGC ACTGTCCG 
GATATACGCAA CTACGTTAAAG ATACGCGTGGG CIIZGAGCCTCG TGACAGGC 
2973 GCTCGCTTCGC TACTTGGAGCC ACTATCGACTA CGCGATCATGG CGACCACA 
CGAGCGAAGCG ATGAACCTCGG TGATAGCTGAT GCGCTAGTACC GCTGGTGT 
2850 CCCTTGAGAGC CTTCAACCCAG TCAGCTCCTTC CGGTGGGCGCG GGGCATGA 
GGGAACTCTCG GAAGTTGGGTC AGTCGAGGAAG GCCACCCGCGC CCCGTACT 
2927 CTTCTTTATCA 'I'GCAACTCGTA GGACAGGTGCC GGCAGCGCTCT C'GGTCATT 
GAAGAAATAGT ACGTTGAGCAT CCTGTCCACGG CCC, 'TCGCGAGA CCCAGTAA 
3004 
3081 
3158 
3235 
3312 
3466 
3543 
3620 
697 
3771 
3851 
4005 
4082 
41~9 
4236 
4313 
4390 
4467 
GCGCGACGATG ATCGGCCTGTC GCTTGCGGTAT TCGGAATCTTG CACGCCCT 
CGCGCTGCTAC TAGCCGGACAG CGAACGCCATA AGCCTTAGAAC GTGCGGGA 
GCCACCAAACG TTTCGGCGAGA AGCAGGCCATT ATCGCCGGCAT GGCGGCCG 
CGGTGGTTTGC AAAGCCGCTCT TCGTCCGGTAA TAGCGGCCGTA CCGCCGGC 
GTTCGCGACGC GAGGCTGGATG GCCTTCCCCAT TATGATTCTTC TCGCTTCC 
CAAGCGCTGCG CTCCGACCTAC CGGAAGGGGTA ATACTAAGAAG AGCGAAGG 
AGGCCATGCTG TCCAGGCAGGT AGATGACGACC ATCAGGGACAG CTTCAAGG 
TCCGGTACGAC AGGTCCGTCCA TCTACTGCTGG TAGTCCCTGTC GAAGTTCC 
ACTTCGATCAC TGGACCGCTGA TCGTCACGGCG ATTTATGCCGC CTCGGCGA 
TGAAGCTAGTG ACCTGGCGACT AGCAGTGCCGC TAAATACGGCG GAGCCGCT 
TGTAGGCGCCG CCCTATACCTT GTCTGCCTCCC CGCGTTGCG1'C GCGGTGCA 
ACATCCGCGGC GGGATATGGAA CAGACGGAGGG GCGCAACGCAC CGCCACG'1' 
TGGAAGCCGGC GGCACCTCGCT AACGGATTCAC CACTCCAAGAA TTGGAGCC 
ACCTTCGGCCG CCGTGGAGCGA TTGCC AAGTG GTGAC;GTTCTT AACCTCGG 
ATGCGCAAACC AACCCTTGGCA GAACATATCCA TCGCGTCCGCC ATCTCCAG 
TACGCGTTTC'G TTGGGAACCGT CTTGTATAGGT AGCGCAGGCGG TAGAGGTC 
AGCGTTGGGTC CTCCCCACGGG TGCGCATGATC GTGCTCCTGTC C'TTGAGGA 
TCGCAACCCAG GACCGGTGCCC ACGCGTACTAG CACGAGGACAG CAACTCCT 
TACTGGTTAGC AGAATGAATCA CCGATACGCGA GCGAACC'TGAA GCGACTGC 
ATGACCAATCG TCTTACTTAGT GGCTATGCGCT CGCTTGCACTT CGCTGACG 
CAACAACATGA ATGGTCTTCGG TTTCCGTGTTT CGTAAAGTCTG GAAACGCG 
GTTGTTGTACT TACCAGAAGCC AAAGGCACAAA GCATTTCAGAC CTTTGCGC 
TTCCGGATCTG CATCGCAGGAT GCTGCTGGCTA CCCTCTGGAAC ACCTACAT 
AAGGCCTAGAC GTAGCGTCCTA CGACGACCGA GGGACACCTTG TGGATGTA 
ACCCTGAGTGA TTTTTCTCTGG TCCCGCCGCAT CCATACCGCCA GTTGTTTA 
TGGGACTCACT AAAAAGAGACC AGGGCGGCGTA GGTATGGCGGT CAACAAAT 
CATGTTCATCA TCAGTAACCCG TATCGTGAGCA TCCTCTCTCGT TTCATCGG 
GTACAAGTAGT AGTCATTGGGC ATAGCACTCGT AGGAGAGAGCA AAGTAGCC 
TCCCCCTTACA CGGAGGCATCA AGTGACCAAAC AGGAAAAAACC GCCCTTAA 
AGGGGGAATGT GCCTCCC;TAGT TCACTGGTTTG TCCTTTTTTGG CGGGAATT 
ACATTAACGCT TCTGGAGAAAC TCAACGAGCTG GACGCGGATGA ACAGGCAG 
TCTAATTGCGA AGACCTCTTTG AGTTGCTC'GAC CTGCGCCTACT TGTCCGTC 
CGCTGA1'GAGC TTTACCGCAGC TGCCTCGCGCG TTTCGGTGATG ACGGTGAA 
GCGACTACTCG AAATGGCGTCG ACGGAGCGCGC AAAGCCACTAC TGCCACTT 
AGACGGTCACA GCTTGTCTGTA AGCGGATGCCG GGAGCAGACAA GCCCGTCA 
TCTGCCAGTGT CGAACAGACAT TCGCCTACGGC CCTCGTCTGTT CGGGCAGT 
TGTCGGGGCGC AGCCATGACCC AGTCACGTAGC GATAGCGGAGT GTATACTG 
ACAGCCCCGCG TCGGTACTGGG TCAGTGCATCG CTATCCCCTCA CATATGAC 
ATTGTACTGAG AGTGCACCATA TGCGGTGTGAA ATACCGCACAG ATGCGTAA 
TAACATGACTC TCACGTGGTAT ACGCCACACTT TATGGCGTGTC TACGC. 'ATT 
114 
46?l 
4698 
4775 
4852 
4929 
5006 
5160 
5237 
5314 
5'l 91 
5468 
5622 
5699 
1776 
59'30 
TTCCGCTTCCT CGCTCACTGAC TCGCTGCGCTC GGTCGTTCGGC TGCGGCGA 
AAGGCGAAGGA GCGAGTGACTG AGCGACGCGAG CCAGCAAGCCG ACGCCGCT 
TAATACGGTTA TCCACAGAATC AGGGGATAACG CAGGAPAGAAC ATGTCAGC 
ATTATGCCAAT AGGTGTCTTAG TCCCCTATTGC GTCCTTTCTTG TACACTCG 
CGT~GGC CGCGTTGCTGG CGTTTTTCCAT AGGCTCCGCCC CCCTGACG 
GCATTTTTCCG GCGCAACGACC GCAAAAAGGTA TCCGAGGCGGG GGGACTGC 
TCAGAGGTGGC GAAACCCGACA GGACTATAAAG ATACCAGGCGT TTCCCCCT 
AGTCTCCACCG CTTTGGGCTGT CCTGATATTTC TATGGTCCGCA AAGGGGGA 
TTCCGACCCTG CCGCTTACCGG ATACCTGTCCG CCTTTCTCCCT TCGGGAAC 
AAGGCTGGGAC GGCGAATGGCC TATGGACAGCC GGAAAGAGGGA EGCCCTTC 
TGTAGGTATCT CAGTTCGGTGT AGGTCGTTCGC TCCAAGCTGGG CTGTGTGC 
ACATCCATAGA GTCAAGCCACA TCCAGCAAGCG AGGTTCCACCC GACACACG 
CTGCGCCTTAT CCGGTAACTAT CGTCTTGAGTC CAACCCGGTAA GACACGAC 
GACGCGGAATA GGCCATTGATA GCAGAACTCAG GTTGGGCCATT CTGTGCTG 
GTAACAGGATT AGCAGAGCGAG GTATGTAGGCG GTGC'ACAGAG TTCTTGAA 
CATTGTCCTAA TCGTCTCGCTC CATACATCCGC CACGATGTCTC AAGAACTT 
AGAAGGACAGT ATTTGGTATCT GCGCTCTGCTG AAGCCAGTTAC CTTCGGAA 
TCTTCCTGTCA TAAACCATAGA CGCGAGACGAC TTCGGTCAATG CAAGCCTT 
CAAACAAACCA CCGCTGGTAGC GGTGGTTTTTT TGTTTGCAAGC AGCAGATT 
GTTTGTTTGGT GGCGACCATCG CCACC~ ACAAACGTTCG TCGTCTAA 
AAGATCCTTTC ATCTTTTCTAC GGGGTCTCACG CTCAGTGGAAC GAAAACTC 
TTCTAGGAAAC TAGAAAAGATG CCCCAGACTGC GAGTCACCTTG CTTTTGAG 
TTATC~G GATCTTCACCT AGATCCTTTTA CGCGCCCTCTA GCGGCGCA 
AATAGTTTTTC CTAGAAGTGCA TCTAGGAAAAT CCGCCGGACAT CGCCGCGT 
CGCGCAGCGTG ACCGCTACACT TGCCAGCGCCC 1'AGCGCCCGCT CCTTTCGC 
GCGCGTCGCAC TGGCGATCTGA ACGGTCGCGGG ATCGCGGGCGA CGAAAGCG 
TTCGCCGGCTT TCCCCGTCAAG CTCTAAATCGG GGGCTCCCTTT AGGGTTCC 
AAGCGGCCGAA AGGGCCAGTTC GAGATTTAGCC CCCGAGGGAAA TCCCAAGG 
CCCCAAAAAAC TTGATTTGGGT GATGGTTCACG TAGTGGGCCAT CGCCCTGA 
GGGGTTTTTTG AACTAAACCCA CTACCAAGTGC ATCACCCGGTA GCGGGACT 
TGCAGTCCACG TTCTTTAATAG TGGACTCTTGT TCCAAACTGGA ACAACACT 
ACCTCAGGTGC AAGAAATTATC ACCTGAGAACA AGGTTTGACCT TGTTGTGA 
GATTTATAAGG GATTTTGCCGA TTTCGGCCTAT TGCTT~A TGAGCTGA 
CTAAATATTCC CTAAAACGGCT AAAGCCGGATA ACCAATTTTTT ACTCGACT 
TAACAAAATAT TAACGTTTACA ATTTAAATATT TGCTTATACAA TC'TCCTG 
ATTGTTTTATA ATTCCAAATGT TAAATTTATAA ACCAATATGTT AGAAGGAC 
Ammmllm 
CCGGGGTAAAT CAATCTAAAGT ATATATGAGTA AACTTGGTCTG ACAGTTAC 
GGCCCCATTTA GTTAGATTTCA TATATACTCAT TTGAACCAGAC TGTCAATG 
An picithn Resistance 
6007 TCTCAGCGATC TGTCTATTTCG TTCATCCATAG TTGCCTGACTC CCCGTCGT 
AGAG'1'CGCTAG ACAGATAAAGC AAGTAGGTATC AACGGACTGAG GGGCAGCA 
Am c;illin Resistance 
6084 TTACCATCTGG CCCCAGTGCTG CAATGATACCG CGAGACCCACG CTCACCGG 
AATGGTAGACC GGGGTCACGAC GTTACTATGGC GCTCTGGGTGC GAGTGGCC 
Ampicillin Resistance 
6361 GCCAGCCGGAA GGGCCGAGCGC AGAAGTGGTCC TGCAACTTTAT CCGCCTCC 
CGGTCGGCCTT CCCGGCTCGCG TCTTCACCAGG ACGTTGAAATA GGCGGAGG 
Anipiclllln Resistiirtce 
6236 AAGCTAGAGTA AGTAGTTCGCC AGTTAATAGTT TGCGCAACGTT GTTGCCAT 
TTCGATCTCAT TCATCAAGCGG TCAATTATCAA ACGCGTTGCAA CAACGGTA 
Antpmlllin Re«rStenee 
6316 TCGTCGTTTGG TATGGCTTCAT TCAGCTCCGGT TCCCAACGATC AAGGCGAG 
AGCAGCAAACC ATACCGAAGTA AGTCGAGGCCA AGGGTTGCTAG TTCCGCTC 
Ampialln Riisistanre 
6392 AAAAGCGGTTA GCTCCTTCGGT CCTCCGATCGT TGTCAGAAGTA AGTTGGCC 
TTTTCGCCAAT CGAGGAAGCCA GGAGGCTAGCA ACAGTCTTCAT TCAACCGG 
Ampi il'in Rassler re 
6469 CAGCACTGCAT AATTCTCTTAC 'I'GTCATGCCAT CCGTAAGATGC TTTTCTGT 
GTCGTGACGTA TTAAGAGAATG ACAGTACGGTA GGCATTCTACG AAAAGACA 
Amttrcttrn Resistance 
6646 TTCTGAGAATA GTGTATGCGGC GACCGAGTTGC TCTTGCCCGGC GTCAACAC 
AAGACTCTTAT CACATACGCCG CTGGCTCAACG AGAACGGGCCG CAGTTGTG 
Am acillst Resets;ice 
6623 AACTTT~G TGCTCATCATT GGA7«AACGTTC TTCGGGGCGAA AACTCTCA 
TTGAAATTTTC ACGAGTAGTAA CCTTTTGCAAG AAGCCCCGCTT TTGAGAGT 
Amp:illin Resist; nce 
6700 GTTCGATGTAA CCCACTCGTGC ACCCAACVGAT CTTCAGCATCT TTTACTTT 
CAAGCTACATT GGGTGAGCACG TGGGTTGACTA GAAGTCGTAGA AAATGAAA 
Amptmllir Resislance 
6177 ACAGGAAGGCA AAATGCCGCAA AAAAGGGAATA AGGGCGACACG GAAATGTT 
TGTCCTTCCGT TTTACGGCGTT TTTTCCCTTAT TCCCGCTGTGC CTTTACAA 
6654 ATATTATTGAA GCATTTATCAG GGTTATTGTCT CATGAGCGGAT ACATATTT 
TATAATAACTT CGTAAATAGTC CCAATAACAGA GTACTCGCCTA TGTATAAA 
6931 TAGGGGTTCCG CGCACATTTCC CCGAAAAGTGC CACCTGACGTC TAAGAAAC 
ATCCCCAAGGC GCGTGTAAAGG GGCTTTTCACG GTGGACTGCAG ATTCTTTG 
EcoRI 
0008 ~TAGGCG TATCACGAGGC CCTTTCGTCTT CAAG 
TTTTTATCCGC ATAGTGCTCCG GGAAAGCAGAA GTTC 
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